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ABSTRACT
Small, biologically active molecules with unique properties and applications are
potential solutions to a wide range of threats to global health including infectious agents
and neurodegenerative disease. Experimental studies on a class of oligomeric p-phenylene
ethynylenes (OPEs) have shown potential both as bioactive antimicrobials and fluorescent
sensing agents for tracking amyloid-β (Aβ) aggregates found in Alzheimer’s Disease (AD).
A second type of small molecule with potential applications in AD therapy, curcumin, has
been found to interfere with Aβ fibril growth. Curcumin also attenuates Aβ-membrane
interactions and Aβ toxicity. Our goal has been to use computational techniques to better
understand the interactions governing small molecule behavior when bound to capsid or
fibrillar protein scaffolds. We focused on mechanistic details involved with the binding of
these compounds. We have also used other modeling techniques to design adaptive devices
to provide aid for those with limited mobility caused by AD and other diseases.
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CHAPTER 1: Introduction and Motivation
1.1 Computer based tools to solve problems at the microscopic and macroscopic
levels
Computational techniques, including modeling and simulations, are a means to
comprehensive engineered design, whether at the microscopic or macroscopic level.
Molecular dynamics (MD) simulations are a powerful tool for predicting the behavior of
molecular systems including DNA structure, protein folding, and ligand-receptor
interactions through modeling chemical and biophysical interactions following Newton’s
equations of motion at the atomic or near atomic level. Accurate resolution above the
atomic level (coarse-grained force fields1) and software/hardware (graphics processing unit
or GPU acceleration2,3) advances have allowed investigation of increased size and lengths.
In addition, a number of MD simulations have been used for pharmaceutical drug design
and screening to enhance optimization of diagnostic agents. My primary graduate projects
have implemented explicit (for production MD) and implicit (for binding energy
calculations) solvent MD geared toward exploration of protein scaffolds and the
implications of their structure on binding of small, bioactive compounds, such as curcumin
(found in the turmeric spice). Specifically, I have focused on protein assemblies important
to Alzheimer’s disease (AD) etiology and the potential of curcumin and oligo p-phenylene
ethynylenes (OPEs) as therapeutic and diagnostic tools for AD.
At the macroscopic scale, there are increasing needs to design and fabricate
adaptive devices to improve activities of daily living (ADL) for people dealing with
challenges caused by factors including neurodegenerative disease and aging. Affordable
and modular devices to help with eating, personal hygiene, and fulfillment of educational
and occupational duties are important for allowing increased time and effort to be placed

1

in quality of life and productivity. This forms the basis of my secondary projects as part of
recent adaptive design efforts in the UNM Biomedical Engineering Department.
As a student with Muscular Dystrophy, MDy, I have a personal passion and desire
to pursue long-term treatment and diagnosis of progressive diseases along with solutions
to prevalent short-term needs accompanying living with a disease. A summary of my
projects is given in Fig. 1.1, all of which involve using computational modeling to either
(i) understand molecular level interactions of biological assemblies including proteins and
lipids with potential bioactive sensors or (ii) design and 3D print devices for rapid
prototyping of medical devices enhanced with biofilm-resistant materials. Through MD
simulations, it has been possible to investigate molecule behavior and interactions “behind
the scenes” that provide a more complete picture of experimental findings of the Chi and
Whitten groups. These studies form the basis for future synergistic efforts with the Evans
lab to optimize OPE structures for protein aggregate sensors, including smaller neurotoxic
species. In addition, along with expert (therapists and rehabilitation specialists) and
Rapid prototyping & 3D printing
of antibacterial medical devices

Protein interactions with
ligands, membranes, and
other peptides

Biological
assemblies

Adaptive
Design
Sensors and
antimicrobials

Figure 1.1. Areas of focus presented in this dissertation. Molecular dynamics
simulations (top left) and computer-aided drafting (top right) link the major
projects.

2

potential user feedback, I will continue working with the Canavan group on prototyping
and eventual production of adaptive devices.

Amino acids

Zika capsid
Viral capsid subunit
Beta sheet

Alpha helix

Amyloid hairpin

Amyloid fibrils

Figure 1.2. Proteins form large, self-assembled scaffolds including viral capsids
and amyloids5,6.
1.2 Protein structure and assembly
Protein structure and function, and misfunction, in specific environments play
significant roles in a number of areas including microbial infection and neurodegenerative
disease. Many viral and bacterial agents infect host organisms through interactions and
attachment to protein specific receptor sites. Moreover, viruses such as Zika are partially
constructed of large self-assembled protein subunits in a specific orientation (icosahedral
capsids) that encase viral genetic material4. At the lowest level, single peptides are
sequences of amino acids attached to one another (much like beads on a string) with
functional groups that directly influence protein secondary structure in which the peptide
chains may adopt more ordered beta-sheets or alpha-helices (Fig. 1.2)5. Specific
arrangements of many beta sheets or helix-enriched peptides allow the formation of tertiary

3

structures that can be found in biomolecules ranging from viral capsid subunits to
substituent monomers of oligomeric and fibrillar protein deposits6 found in
neurodegenerative diseases. In fact, over 50 diseases in humans involve aggregates of
misfolded proteins into plaques or lesions observed in AD, Parkinson’s disease (PD), type2 diabetes, amyotrophic lateral sclerosis (ALS) to name a few7. Many of the proteins found
in these diseases are intrinsically disordered naturally, meaning they do not have a defined
secondary or tertiary structure. However, in the disease state, they become aggregate prone
and form insoluble fibrils as shown in Fig. 1.2.
1.3 Misfolded proteins in neurodegenerative disease
2.
BACKGROUND AND SIGNIFICANCE
AD and a host of other neurodegenerative diseases including PD and diabetes
2.1 Protein misfolding and aggregation is implicated in a myriad of diseases. Since the discovery
by Alois Alzheimer over a century ago that the postmortem brains of his severely demented patients
10
feature hallmark
lesions
composed
of large
aggregates
misfolded
1.3
contain proteinaceous
amyloid
plaques
, much has
been learned
aboutofthese
plaquesproteins.
and their Fig.
role in
disease etiology. The plaques are made of fibrillar aggregates of
the amyloid-b
(Ab)
its aggregation
is believed
to
shows
thepeptide
similarandpathological
features
among
initiate a cascade of pathological events, spanning up to two
decades, that culminates in neurodegeneration and cognitive
11-17
of these
diseases.
Although
each of the
decline in several
Alzheimer’s
disease
(AD) patients
. Moreover,
the
aberrantly folded proteins, wherein a protein misfolds from its
native structure
into the
b-sheet
proteinsand
haveself-assembles
different functions
andhighly
are unrelated
enriched fibrils, are found in about 50 other human diseases,
including neurodegenerative disorders such as Parkinson’s
in native structure, the self-assembly into
(PD), Huntington’s, and chronic traumatic encephalopathy,
diseases of particular organs, including cardiomyopathy, type-2
fibrils orand
amyloids
is observed
with all
diabetes, insoluble
and liver cirrhosis,
systemic
diseases, including
5, 18-22 5,
senile systemic amyloidosis and light-chain amyloidosis
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1: Misfolding
and aggregation
of
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1.3 Misfolded
proteins
(Fig.
Currently,
there
is no
prevention
of 1).
them.
In AD,
there
areearly
twodetection,
proteins that
form proteins
into b-sheet rich insoluble fibrils
fibrillar deposits in a
or cure for these protein misfolding diseases, which is due to, at isform
a common pathological feature (dark
75
least in part, our lack of understanding of many fundamental inclusions)
plethora of
human
diseases
in many
disease
states. .
amyloidogenic
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namely
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aspects of the protein aggregation process.
2.2 Early
events
are critical in
in microtubule
protein aggregation
and
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The the
assembly
proteins into
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tau (important
structural
stability)
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aggregates containing non-native structures involves at least two critical steps, conformational change to
27-30
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. We have shown that the first step
amyloid-β (Aβ)
forms
from cleavage
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the transmembrane amyloid
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requires perturbation
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structure
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the assembly
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. function
The energy
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the two steps
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protein
by α- and
of APP
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aggregation of natively folded proteins are reflected in the values of free energy of unfolding (DGunf) and
osmotic second virial coefficient (B22), respectively. Thus, aggregation is fundamentally an interplay
While these amyloids are common neuropathological indicators28-30.of
between the conformational stability of the protein and the colloidal stability of the protein solution
Depending on the magnitudes of the two energy barriers, either could be rate-limiting.
neurodegenerative
disease,
it has
become
increasingly
apparent
aggregates,
Another
fundamental aspect
of amyloid
protein
aggregation
is the creation
of that
a newsmaller
interface
between
31
the solution phase and the newly condensed fibrillar phase . Kinetics of fibril formation follows a
32-39
nucleation
dependent-polymerization
model of, Aβ,
where
growth profile
is characteristically
such
as oligomers and protofibrils
are fibril
the primary
neurotoxic
agents in AD
sigmoidal. Soluble native protein first undergoes a slow (high energy barrier) nucleation step during which
the protein becomes aggregation-competent and forms oligomeric species, followed by a fast growth step
in which oligomers rapidly grow through protein addition to generate protofibrils that further mature into
4
fibrils (homogeneous nucleation pathway in Fig. 3). The nucleation
step is rate-limiting and not yet wellunderstood. Elucidating the conditions and details of the structural rearrangements that lead to nucleation
is of great relevance and importance as it is the first step that needs to be understood in order to control
or inhibit amyloid protein aggregation in a systematic way.

ACS Omega

Table 1. Structures of the 18 PPE-Based Oligomers and P
progression9. Soluble, non-fibrillar species of Aβ (mostly 40- and 42-amino acid varieties)
have shown high neurotoxicity in experimental studies10–13. In fact, Kayed and coworkers
report toxicity and size of Aβ aggregates as inversely correlated9. Our computational
studies presented in this work have focused on investigation of Aβ40-based oligomers and
protofibrils enriched in beta-sheet conformations, which are of the toxic size range
(aggregates less than 32 peptides in length) discussed in a review by Sengupta and
colleagues9. In particular, we have investigated predominantly pentamers and 24-mers of
Aβ and their interactions with small, organic molecules.
1.4 Oligomeric conjugated polyelectrolytes
Oligomers and polymers with a
OR

p-phenylene (PE) backbone have been
investigated in computational and

R’

R’
n
RO

experimental work by the Whitten
group and others for their promising
applications

in

antimicrobial

and

Figure 1.4. General OPE structure with
repeat length, n, side groups, R, and end
groups, R’, shown.

biomolecular sensing due to their tailorable structure and ability to produce singlet oxygen,
which causes destruction of viral capsids and bacterial membranes14–16. OPEs (general
structure shown in Fig. 1.4) feature a rigid, highly conjugated backbone with phenyl and
ethynyl moieties with charge groups either on the ends or sides. The simulation studies
described in Chapters 2 and 3 of this dissertation indicate these properties enable OPEs to
bind non-specifically to protein aggregates.
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T4 phage. This could be due in part to the presence of 32 pores14
(1.8 nm in diameter) on the MS2 capsid that provide easier
access for the oligomers to interact with the packaged phage
genome. It is also worth noting that long wavelength UV!visible
light (LZC-420) alone produces negligible inactivation of the
viruses (UV control data for polymeric PPE-DABCO and PPE-Th
samples in Figure 1). In contrast, UVA irradiation in the absence
of the oligomers causes measurable inactivation of both viruses

that because the sorption of the CPEs and OPEs to the viral
particles is not fully understood, it is possible for the absorbed
antiviral compounds to be desorbed with a change in the
environmental conditions (such as solution pH and ionic
strength) without causing lethal damage to the bacteriophages.
We have shown previously that the CPE and OPE compounds
can disrupt noncovalent biomolecular assemblies11 and generate
reactive oxygen species with UV!visible light exposure, which
can strongly damage biomolecules, including proteins that make

Previous biocidal studies17–19 have found a number of conjugate polyelectrolytes

Figure 2. TEM images of the T4 and MS2 viruses alone (A1 and A2) and incubated with PPE-DABCO (B1 and B2, in the dark; C1 and C2, with UV
irradiation) or EO-OPE-1 (Th) (D1 and D2, in the dark; E1 and E2, with UV irradiation) for one hour. The scale bars of the T4 images are 100 nm, and
the scale bars of the MS2 images are 20 nm.
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More recently, OPEs have demonstrated promising potential as biosensors for
aggregates of misfolded proteins found in AD and PD, with significant improvements in
the sensitivity and specificity of detection compared to dyes such as Thioflavin T and
Congo red24,25. The increases in fluorescence intensity when OPEs are in the presence of
fibrillar and oligomeric Aβ compared to monomeric protein26 was initially found to occur
for two model proteins, insulin and lysozyme27. A range of OPE-amyloid aggregate sensing
properties have been elucidated by the Whitten and Chi groups including OPE binding
constants and amyloid detection factors (ADF). The ADF values showed two types of
compounds with ethyl ester end groups and either anionic or cationic functional groups
were best suited for further testing in mouse and rat models26–28. This information led us to
begin a series of computational studies to better understand the mechanistic driving forces
behind OPE interactions with Aβ.
1.5 A brief discussion of molecular dynamics fundamentals
MD simulations have been used in numerous studies involving protein folding,
lipid structure and destabilization, ligand-receptor interactions, and other biological
systems. Early simulations of biomolecules, including proteins such as trypsin inhibitors
approximately 50-amino acids in size, were studied in the 1970s by the Karplus group at
the picosecond timescale29. These efforts followed from simulations involving fluid
thermodynamic analysis of liquids including argon30 and water31. Current simulations are
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able to reach nano- to microsecond timescales for systems containing hundreds of
• Empirical method for calculating energy in a
32–34
molecular
system
thousands of atoms
. The
forces and their dynamic behavior in typical all-atom MD

∂ 2rNewton’s
simulations of biological systems stem from
equations of motion:
mi 2i = Fi
∂t
• Two components
∂V
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– Functional form
i i =−
∂ri
– Parameter set

V (r ) = ∑ E bonded + ∑ E nonbonded
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€

(1.1)

where Fi is the force on each atom (position ri) as a function of the potential energy, V, of
the system. In MD, the velocities and positions are used to iteratively compute these forces
and update them in a sequential fashion thereby providing a simulation trajectory for
analysis. The force field (potential energy) of biophysical systems are described, with
variations depending on the model used, by the following potential energy function. In
protein and biomolecular simulations the potential function consists of bonded (Ebonded) and
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nonbonded terms (Enonbonded):
(1.2)
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force field35,36 describes the bonded interactions due to vibrational motion of the molecule
€

Nonbonded terms
with bond (b), angle (θ), and dihedral terms (angle ϕ and phase shift
𝛿) along with

appropriate force constants. Nonbonded interactions,
namely van der Waals (varying with
Bonded terms

What is a Force Field?

atomic distance, r) and electrostatic interactions (between charges q1 and q2), are modeled
by Lennard-Jones and Coulombic potentials, respectively, as shown in equation 1.3.
V (r ) = ∑ E bonded + ∑ E nonbonded
V (r ) =

& A C qq )
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pairs

electrostatic interactions consist of both short range (Coulombic) and long-range
Nonbonded terms

components with the latter often computed using the Particle Mesh Ewald sum (PME)
Bonded
terms
method37 when periodic boundary
conditions
(PBC) are used.

In order to simulate biological systems at physiological temperature and pH, two
types of ensemble known as the canonical or NVT (constant number of particles, N,
constant volume, V, and constant temperature, T) ensemble and isothermal-isobaric or
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NPT (constant number of particles, N, constant pressure, P, and constant temperature, T)
ensemble are used38. The simulations used for data collection in this dissertation employ
the NPT ensemble to model an environment at ambient temperature and pressure after NVT
equilbration.
Modeling the solvent environment explicitly is a challenge due to the high
computational cost involved in calculating the forces on a system that is hundreds of
thousands of atoms in size. Therefore, implicit solvent models are often implemented with
a continuum model and appropriate dielectric constant to describe screening effects.
Binding energy calculations often utilize implicit solvent approximations such as the
generalized Born surface area (GBSA)39 model to improve the calculation efficiency. In
the MD simulations presented in this work, we utilize the GBSA model for determining
energetics of binding between protein assemblies and small molecules including OPEs.
1.6 Summary
Computational

approaches

that

complement

and

enhance

experimental

observations are essential for improving our understanding of molecular scale events or for
allowing optimization of engineered devices prior to fabrication. The MD based simulation
projects described in this work are aimed at using knowledge gleaned from previous
experimental studies of bioactive compounds with systems involving large assemblies of
biological molecules including misfolded proteins. The second area of focus implements
computer aided drafting (CAD) design and 3D printing with the eventual goal of producing
adaptive, modular devices for improving the unique daily living needs caused by a number
of debilitating factors including surgery and neurodegenerative disease. Both areas of

9

research will contribute to short term needs for dealing with disease symptoms and longterm solutions to alleviate or reverse them.
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CHAPTER 2: Oligomeric Conjugated Polyelectrolytes Display SitePreferential Binding to MS2 Viral Capsid
(This chapter has been published in Langmuir and appears as Tye D. Martin, Eric H. Hill,
David G. Whitten, Eva Y. Chi, and Deborah G. Evans. Oligomeric Conjugated
Polyelectrolytes Display Site-Preferential Binding to MS2 Viral Capsid, Langmuir 2016,
32, 12542−12551)
ABSTRACT
Opportunistic bacteria and viruses are a worldwide health threat prompting the need
for developing new targeting modalities. A class of novel synthetic poly(pheylene
ethynylene) (PPE) based oligomeric conjugated polyelectrolytes (OPEs) has demonstrated
potent wide-spectrum biocidal activity. A subset of cationic OPEs display high antiviral
activity against the MS2 bacteriophage. The oligomers have been found to inactivate the
bacteriophage and perturb the morphology of the MS2 viral capsid. However, details of the
initial binding and interactions between the OPEs and the viruses are not well understood.
In this study, we use a multi-scale computational approach, including random sampling,
molecular dynamics, and electronic structure calculations, to gain an understanding of the
molecular level interactions of a series of OPEs that vary in length, charge, and functional
groups with the MS2 capsid. Our results show that OPEs strongly bind to the MS2 capsid
protein assembly with binding energies of up to -30 kcal/mol. Free energy analysis shows
that the binding is dominated by strong van der Waals interactions between the
hydrophobic OPE backbone and the capsid surface and strong electrostatic free energy
contributions between the OPE charged moieties and charged residues on the capsid
surface. This knowledge provides molecular level insight of how to tailor the OPEs to
optimize viral capsid disruption and increase OPE efficacy to target amphiphilic protein
coats of icosahedral based viruses.
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2.1 INTRODUCTION
Infectious diseases caused by antibiotic-resistant pathogenic bacteria and viruses
remain a worldwide health threat, prompting the development of treatments with nonspecific biocidal mechanisms1. A novel class of poly(phenylene ethynylene) (PPE)-based
conjugated polyelectrolytes (CPE) and oligomers (OPEs) (Figure 2.1) has demonstrated
biocidal activity towards a broad spectrum of bacteria, spores, and viruses2-4. In addition
to biocidal applications, the photophysical properties of the CPE and OPE compounds have
led to applications in conducting materials and biomolecular sensing5,6. The OPEs in
particular are also highly tailorable; compounds with varying lengths, side and end groups,
and charge distribution have been synthesized5. A subset of cationic OPEs has been shown
to kill both Gram-positive and Gram-negative bacteria under UV irradiation due to the
production of singlet oxygen species2. The effectiveness and behavior of these compounds
are currently being explored with synergistic computational and experimental approaches
to better elucidate the mechanisms of their biocidal activities.
In recent molecular dynamics (MD) simulations conducted on OPEs with lipid
bilayers, OPEs were found to disrupt the membrane structure and induce the formation of
pores in the lipid membrane, allowing water to cross the membrane7,8. Additionally, lipid
flip-flop was also induced by OPE interactions with the lipid membrane. It was found that
the OPEs that inserted into the membranes displayed a conjugated backbone with an
optimal length that spans both membrane leaflets and four charge groups that act as a
“ladder” for water molecules to traverse. This finding describes one possible mechanism
by which OPEs exert antimicrobial activity even in the absence of UV light irradiation7,8.
It is evident from this work, along with other studies on similar protein-ligand interactions,
including fibrillar protein interactions with fluorescent dyes9, that theoretical tools such as
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MD can give molecular level insights into ligand binding with biological assemblies10.
Combined with experimental measurements of OPE biological activities and functional
properties, our findings will enable us to elucidate the structure-function relationship of
this novel class of bio-active compounds.
Recent experimental studies conducted using OPEs on bacteria-based viruses,
namely MS2 and T4, demonstrated strong antiviral properties4. Under UV exposure,
reactive oxygen species (ROS) generated by these compounds causes capsid destruction
and eventual leakage of genetic material. Furthermore, the morphology of the
bacteriophage became drastically disrupted after incubation with several different OPE and
CPE compounds in the dark. It is hypothesized that OPEs coat the capsid surface and
thereby inhibit normal viral function11-17. Of the OPEs studied, the cationic compounds
were found to be particularly effective at inactivating viruses, possibly due to favorable
electrostatic interactions with the overall negatively charged MS2 capsid. Increasing the
length of the conjugated backbone was found to enhance their antiviral activity, possibly
due to increased binding to the viral surface. The two OPEs that exhibited the highest
antiviral activities in the dark were EO-TH-OPE1+ and OPE3+. The first, EO-TH-OPE1+,
is an “end-only” compound with no side chains (Figure 2.1, Compound 4), whereas the
second compound, OPE3+, is larger and has six cationic side chains4.
It is clear from our previous study that OPEs are effective virucides and that the
antiviral activity of the compounds depends on their charge, size, and structure4. However,
the molecular level interactions of the OPEs with the viral capsid, the first point of contact,
and the mechanism by which viral inactivation takes place in the dark are unclear. In this
study, we use a combination of molecular docking, MD and electronic structure
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calculations to investigate the interactions between a number of OPEs and the MS2 viral
capsid.
MS2 is a RNA based virion, with a 27 nm diameter capsid, that typically infects E.
coli12. A crystal structure of the viral capsid (Figure 2.1) shows that the MS2 capsid consists
of 180 copies of repeated trimeric polypeptide subunits that form an icosahedral shell12.
For this study, a pentameric subsection around a single pore (highlighted surface in Figure
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Figure 2.1 Structures of the five OPEs (left) used in this study. Compounds 1 and 4 have a
net charge of +2, compound 2 has a net charge of -2, and compounds 3 and 5 each have a net
charge of +4. The MS2 viral capsid (PDB code 2MS2) is shown on the right. The blue region
indicates the truncated pentameric segment that was used for this study (with individual
pentameric units colored differently).

2.1) was used for simulation studies as it provided an adequate system size and more
efficient use of computation time than the full capsid. Five different OPEs (Figure 2.1,
Compounds 1 to 5) were used to study the effects of OPE charge, size, structure, and
hydrophobicity on interactions with the MS2 viral capsid. OPEs selected for this study
sample a range of properties including anionic and cationic charge groups in addition to
short and long PPE backbones. Four cationic compounds, including S-OPE1+ (Compound
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1), OPE-2+ (Compound 3), EO-TH-OPE1+ (Compound 4), and EO-DABCO-OPE1+
(Compound 5), were used in this study. We also included an anionic compound, S-OPE1(Compound 2), in this study to further test the effect of electrostatic interactions on OPEviral capsid binding.
Molecular docking techniques and MD simulations were carried out to study the
binding of OPEs to the viral capsid. Docking, based on random sampling, has been used
extensively to analyze binding of ligands to receptor complexes and to predict
corresponding energetic affinities18-22. This approach provides a set of likely binding sites
for subsequent analysis using more rigorous techniques. Each OPE binding mode and
“pocket” residues were then extracted for MD-based simulation to examine the binding
events over time. MD simulations can lend insight into binding mechanisms of molecular
level events, including viral inhibition and behavior of biosensory molecules23-30.

MD

simulates all atoms of a system over time and allows interaction energies between ligands
and proteins to be calculated. MD also allows inclusion of explicit solvent and ions and
offers more flexibility for larger components such as proteins. Trajectories obtained via
MD provide energetic information on binding, which were analyzed and compared for all
five OPEs.
To further refine and understand the capsid-bound OPE conformations adopted
during MD, we used density functional theory (DFT) calculations to perform energy scans
along the PPE backbones. The potential energy profiles obtained from DFT allowed us to
gain additional insights into the conformational changes the OPEs undergo when bound to
the capsid surface by comparing positions sampled during MD simulation to the optimized
structures in vacuum. The knowledge gleaned from this computational study, coupled with
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experimental observations, will aid in the rational design of compounds that display
increased antiviral activity and specificity towards icosahedral based viruses.
2.2 MATERIALS AND METHODS
2.2.1 Initial Structures
Structures of the 5 different OPEs were built using the GaussView 5 package33
(Figure 2.1). The preliminary crystallographic structure for the MS2 capsid was obtained
from RCSB PDB (reference, ID 2MS2)34 and then truncated for docking prediction. Due
to the large number of particles in the MS2 capsid (over 300,000 atoms), we selected a
pentameric subsection around a single pore for docking simulations (highlighted surface in
Figure 2.1). As the junctions or interfaces between subunits could play a role in OPEprotein interactions, the inclusion of multiple trimers in our system is expected to
adequately capture the effects and interactions at these subunit interfaces.
2.2.2 Docking
The Autodock Tools interface was used to define the region for the docking study
with grid spacing of 1 Å35. Water molecules were removed from the crystal structure of
protein and hydrogen atoms were added for saturation. Torsion angles contained in the side
and end charge groups were allowed to rotate. Gasteiger charges were computed and nonpolar hydrogen atoms were merged. Other parameters were kept at default settings and
values. The grid box around the truncated region was positioned only on the outer capsid
surface that would be exposed to the exterior in biological environments. The grid box
dimensions were specified as 126 x 126 x 30 grid points with 1 Å spacing. The search
exhaustiveness was set at 8. Multiple iterations were run with 9 predicted OPE modes or
conformations produced per run and random seeding was allowed to change with each
iteration. The calculations in the docking portion of the study were performed with the
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Autodock Vina program (v1.1)36. This package was selected due to its ability to determine
bound conformations with acceptable accuracy and allowance of some ligand flexibility.
The docking program implements a scoring-based function to predict chemical potentials
within the system. A minimum of 100 docked OPE conformations or modes were
combined to compare binding behavior between different OPEs. The charged and
hydrophobic residues of the capsid segment were colored with UCSF Chimera37.
2.2.3 Molecular Dynamics
Molecular dynamics simulations for OPE-protein complexes were performed using
the AMBER12.0 program suite38. Periodic boundary conditions were implemented with a
cutoff for non-bonded interactions of 8 Å. In all simulations hydrogen containing bonds
were restrained and force evaluations for bonds with these atoms were omitted. The preproduction process started with 1000 steps of steepest descent minimization followed by
500 cycles of conjugate gradient minimization. A heating run was used to bring the system
to a temperature of 300 K. The Langevin temperature thermostat was used without
coupling to hydrogens and with a collision frequency of 2. The system was then allowed
to reach a target pressure of 1 atm over 50 ps followed by equilibrating at constant volume
(NPT ensemble) for 5 ns. Full production runs using the NPT ensemble were conducted on
each system until 20 ns was reached. Each OPE-capsid complex (one OPE per complex)
was solvated with approximately 25,000 water molecules and counter ions were added to
ensure a properly neutralized system. Four capsid peptide chains (516 total residues)
composed the capsid component of the MD simulations.
2.2.4 Molecular mechanics generalized Born/surface area calculations (MM-GBSA)
MM-GBSA post-processing calculations were implemented to estimate binding
energies39. The total binding energies ( ΔGBind ) is the sum of the gas phase component
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(∆GMM) and a dielectric component (∆GGBSA) (Equation 2.1):
(2.1)

ΔGBind = ΔGMM + ΔGGBSA

∆GMM is the gas-phase interaction energy between the protein and the ligand and it is
calculated as the sum of electrostatic (∆GEL) and van der Waals (∆GVDW) components in
vacuum (Equation 2.2).
(2.2)

ΔGBind = ΔGEL + ΔGVDW

The dielectric component, or the solvation free energy ∆GGBSA, is the sum of polar (∆GGB)
and nonpolar (∆GSA) energies as a result of the transition from vacuum to a dielectric
environment (Equation 2.3).
(2.3)

ΔGGBSA = ΔGGB + ΔGSA

∆GGB is the electrostatic solvation energy, that is, change in free energy when a molecule
is placed from vacuum into a dielectric medium, calculated using a generalized Born
approximation to reduce the required computation time. Entropy contributions using
normal mode analysis were not performed in our study which explores the relative binding
energetics between similar OPEs and the same capsid subsection. The approach to
determine entropic contributions to binding energies in large protein-ligand systems
presents a significant challenge due to the number of translational, rotational, and
vibrational energy changes involved as described by Kollman and coworkers40. In addition,
there are often large inaccuracies in these values even if successfully calculated and since
this contribution is expected to be constant across the comparative binding study, it is
typically omitted41.
2.2.5 Electronic structure calculations. The MD results were further analyzed using
electronic structure methods with density functional theory (DFT), through the Gaussian
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09 software package33. The OPE conformations following 20 ns of MD simulation were
used to perform dihedral scans along the PPE backbone using DFT. These DFT level
calculations were implemented using the hybrid B3LYP (Becke, three-parameter, LeeYang-Parr) exchange-correlation energy functional42. This level of theory incorporates an
efficient method of considering electron correlation in larger molecules with reasonable
cost and resource requirements. These scans for each OPE were completed using the 631g** basis sets. Dihedral angle energy scans were performed by rotating the torsions
between adjacent phenyl groups in 20° increments. Potential energy contour surfaces were
plotted to locate the energy minima and corresponding ring positions.
2.3 RESULTS AND DISCUSSION
2.3.1 Site-preferential binding of OPE to capsid surface
Results from docking studies show that all of the OPEs favorably interact with the
MS2 capsid segment, where DG values of binding were around -6 kcal/mol (Table 2.1).
The cationic end-only EO-DABCO-OPE1+ (5) showed the strongest affinity, with a DG
value of -6.73 kcal/mol. Corresponding binding constants (K) were also calculated from
DG values using Equation 2.4:
⎛ ΔG ⎞
K = exp ⎜ −
⎟
⎝ RT ⎠

(2.4)

where T is the temperature (300 K) and R is the universal gas constant. The large K values
(Table 2.1) indicate that the interactions between the OPEs and the viral capsid are
favorable. Observation of the top bound conformations of OPEs revealed that the OPEs
display distinct binding patterns on the capsid surface and that the crevices along the capsid
surface were common and high probability binding sites (Figures 2.2, 2.3, and 2.4). Figure
2.2 displays the top 100 binding modes of every OPE. As shown, OPE binding was largely
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to distinct sites on the capsid surface, rather than diffuse, non-specific binding to the entire
capsid surface. Contour views of the top 100 binding sites of S-OPE1+ (compound 1,
Figure 2.3A) and OPE2+ (compound 3, Figure 2.3B) show that the favorable binding sites
are largely grooves along the surface. Furthermore, there is significant overlap among the
top ten predicted binding sites for the OPEs (Figure 2.4). A close-up view of a common
binding site showed that the OPEs were located at the junctions where two pentameric
units are non-covalently adjoined (Figure 2.4). These sites are readily accessible for OPEs
to bind as their crevice-like contour can accommodate the compounds such that a large
number of contacts can be made between the OPEs and the capsid residues. The total
number of residues within 5 Å of each OPE ranged from 30 for SOPE1- (2) to 46 residues
for OPE2+ (3). While not the only factor in determining binding location in these pockets,
it is apparent from the docking results that the locations on the capsid with the least steric
hindrance, such as grooves, allow the OPEs to bind more easily.

Table 2.1. Average OPE-MS2 capsid binding affinity
and free energy of binding (DGbind) values estimated
from docking and MD simulations at 300 K,
respectively.

OPE
1
2
3
4
5

Docking Affinity
(kcal/mol)
-6.24 ± 0.17
-6.68 ± 0.18
-6.26 ± 0.16
-5.93 ± 0.08
-6.73 ± 0.11
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MD ΔG Bind
(kcal/mol)
-30.2 +/- 0.11
-26.7 +/- 0.19
-12.5 +/- 0.17
-22.8 +/- 0.12
-17.3 +/- 0.09

Despite some common features of OPE binding, the OPEs also show distinct binding
patterns (Figure 2.2) on the five biological units surrounding a central pore. S-OPE1+ (1)
was predicted to bind
numerous

locations

1.

A.

(Figure 2.4(1)) whereas

Hydrophilic
Hydrophobic

5.

2.

the larger (4) and (5)
and anionic (2) OPEs
bound to much fewer
4.

sites on the capsid

3.

segment (Figure 2.2).
To further assess the
pattern

of
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the
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(Figure
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determined with the
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Chimera

Figure 2.2 Top 100 binding predictions of OPEs (black)
from docking simulations on hydrophobic (orange) /
hydrophilic (white) (A) and charge surface (B) representation
of the capsid segment shown in Figure 2B. Charges were
assigned at neutral pH.

package. As shown, the capsid surface is extensively populated with hydrophobic residues
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(see orange patches in central image of Figure 2A). The binding patterns of the 5 OPEs
(Figure 2.2A) on the capsid surface indicate that hydrophobic sites provide favorable
binding sites for these OPEs. Upon closer inspection, it is apparent that the hydrophobic
PPE backbones of the

A

S-OPE1+

B

OPE2+

OPEs bind to hydrophobic
grooves

on the capsid

surface

(Figure

2.3A),

while the charged OPE
functional groups (cyan
spheres) extend away from
the backbone to interact
with ionic side chains of the
capsid.

OPE

binding

patterns on the electrostatic
surface representation of
the capsid segment (Figure
2.2B) show that while OPE

Figure 2.3 Contour representation of the top 100
binding predictions of OPEs 1 and 3 bound to the capsid
surface. OPE backbones are shown in black with charge
groups indicated in cyan. The capsid is represented by
an electrostatic surface with red, blue, and white
indicating negative, positive, and neutrally charged
residues, respectively.

backbones lie in hydrophobic rich areas, these areas are also in the vicinity of concentrated
charge so that charged OPE side chains can interact with charged residues on the capsid
surface. Interestingly, the binding sites for all five compounds display both positive and
negative residues.
2.3.2 Dynamics of OPE binding to capsid surface
It is clear from the docking study that the OPEs bind strongly and specifically to the
MS2 capsid surface. However, docking programs typically provide only a rough estimate
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of binding locations and are often limited both by scoring function and restricted receptor
movement22. To further scrutinize the molecular-scale behavior of these systems, we
performed classical MD simulations on capsid subsections with MM-GBSA
implementation to obtain more information on binding free energies and the individual
component contributions. MD also calculates the interactions of all atoms in the system,
while allowing more degrees of freedom for both the OPEs and the capsid residues.
For MD simulations a single OPE with the highest binding score from the docking
studies was extracted along with the capsid peptide chains making up the binding pocket
(4 chains for each system and 516 residues). Partial atomic charges for all OPEs were fitted
using density functional theory electrostatic potential (RESP)43 calculations with atom
types obtained from the generalized Amber force field (GAFF)44. Truncated capsid protein
sections were selected in order to reduce the necessary computation time to reach 20 ns.
Following MD production with periodic boundary conditions, root-mean-squared
deviation (RMSD) plots were generated to observe system stability (Figure 2.5). It can be
seen in Figure 2.5A that system coordinate deviations for the OPE-capsid complexes begin
stabilizing during the 20 ns relative to the movement of the bound OPEs (Figure 2.5B).
The OPEs remained close to the original binding sites that were predicted by docking
studies prior to MD simulation.
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To visualize OPE
structural changes that
had

Figure 2.4 Overlay of the top 10 predicted docking modes
for the OPEs showing common binding sites around a
central pore. S-OPE1+ (1), S-OPE1- (2), OPE2+ (3), EOTH-OPE1+ (4), and EO-DABCO-OPE1+ (5) are colored
lime, pink, yellow, cyan, and red, respectively. Pentameric
units of the capsid are colored differently to highlight OPE
binding in grooves.

occurred

during

MD

simulation,

structures

of

OPEs

before (0 ns) and 10 and
20

ns

simulations

after

MD
were

extracted and compared

(Figure 2.6). Some of the OPEs during the time course showed changes in their
conformations while bound on the protein surface, especially S-OPE1- (2) (Figure 2.6) at
10 ns with part of its PPE backbone extending outward. Functional moieties on the side of
the PPE backbones of compounds 1, 2 and 3 moved readily. EO-TH-OPE1+ (4) displays a
small extent of end group movement during MD simulation. In contrast, end groups of EODABCO-OPE1+ (5) were quite mobile as they bent readily and at different angles
throughout the simulation (Figure 2.6).
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Whereas the OPE-protein complexes stabilized, the RMSD plots of the OPEs
themselves when bound to the capsid showed larger deviations (Figure 2.5B). In contrast,

A.

4

RMSD (Å)

3
S-OPE1+ (1)
S-OPE1- (2)
OPE2+ (3)
EO-TH-OPE1+ (4)
EO-DABCO-OPE1+ (5)

2
1
0

B.

7

0

5

10

15

20

0

5

10
ns

15

20

6

RMSD (Å)

5
4
3
2
1
0

Figure 2.5 RMSD plots of OPE-protein complexes (top) and for bound OPE
(bottom) over the course of 20 ns of MD simulation.

the RMSDs of the backbones of all five OPEs (excluding charge groups) were stable
indicating that the majority of larger conformational changes come from the OPE charge
groups moving between oppositely charged sites on the capsid. The increased structural
fluctuation is supported by movement of their functional groups (Figure 2.6). Interestingly,
in vacuum OPEs typically adopt conformations with charge groups extended away from
the PPE backbone as far as possible. However, the charge group repositioning when
interacting with the capsid clearly demonstrates varying trends ranging from close
backbone proximity to full extension. This suggests that binding of OPEs at the capsid
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interface is sufficiently strong to induce conformational changes that differ from those in
the solution phase.
2.3.3 Energetics of OPE binding to capsid surface
MM-GBSA calculations were used to obtain more accurate estimates for the OPEcapsid binding affinities and to gain insight into the specific energetic contributions to the
interactions. In these post-processing calculations, the total binding energy ( ΔGBind ) is the
sum of all contributions from the capsid protein, OPE, and OPE-capsid complex in vacuum
and when placed in a solvent continuum with an embedded dielectric constant according
to Equations 2.1-2.3 (combined in Equation 2.5):

ΔGBind = ΔGEL + ΔGVDW + ΔGGB + ΔGSA

(2.5)

where ∆GEL, ∆GVDW, ∆GGB, ∆GSA represent the electrostatic, van der Waals, generalized
Born, and solvent accessible surface area energetic components, respectively.

ΔGBind values calculated were negative for all 5 OPEs (Figure 2.7), indicative of
favorable binding interactions. Compared to values obtained from docking simulations
(Table 2.1), these binding energies were larger and spanned a larger range (from about -12
to -30 kcal/mol). The smaller cationic S-OPE1+ (1) exhibited the highest binding energy
with a ΔGBind value of -30 kcal/mol while the larger, more positively charged OPE2+ (3)
showed the lowest ΔGBind value at -12 kcal/mol. The stronger binding exhibited by the
smaller OPEs is likely due to less steric hindrance and more unrestricted access to capsid
crevices.
A breakdown of the binding energy components (Figure 2.7) show that contributions
from electrostatic interactions (ΔGEL), van der Waals (∆GVDW), and solvent accessible
surface areas (∆GSA) are all negative, favoring OPE binding to capsid, while polar solvation
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free energies (ΔGGB) are large and positive, disfavoring OPE binding to capsid. Favorable
electrostatic interactions in vacuum arises from the binding of OPE’s charged side chains
with oppositely charged protein residues

0 ns

10 ns

20 ns

OPE

on the capsid surface. The contribution
from

ΔGGB

usually

acts

1

against

electrostatic binding interactions (as it
2

does in this case), indicating that forming
the complex in a dielectric continuum
environment is unfavorable (the sum of

3

ΔGEL and ΔGGB is greater than zero) if
only these factors were taken into
consideration35.

However,

favorable
4

contributions to binding from van der
Waals (ΔGVDW) interactions along with
small

contributions

from

solvent

accessible surface area effects (ΔGSA)
5

overcome this unfavorable solvation
effect, giving rise to overall favorable
binding interactions, albeit small in
magnitude. This type of small, marginally
stable binding stemming largely from
opposing contributions is characteristic
for macromolecular interactions, for

Figure 2.6 Snapshots of OPE structures
during MD simulation time course. The
phenylene ethynylene backbones favor a
planar position while the OPE side chains
proximity to the backbone varies for each
compound. The functional groups of SOPE1- (2) and EO-DABCO-OPE1+ (5)
show the most notable movement.
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example, protein folding stability.
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Figure 2.7 Energetic component contributions of OPE-protein complexes with
the total binding energies given below in kcal/mol. Values were obtained with
MM-GBSA calculations after 20 ns of simulation in AmberMD.

2.3.4 Residue-specific contributions to OPE binding. To gain a better understanding of
the roles key residues play in OPE binding, select protein residues in the binding pocket
were mutated and the effects of these mutations on binding energetics were examined.
Replacing select residues of the wildtype protein with alanine is commonly implemented
for ligand-receptor based free energy calculations as a way to obtain detailed information
of intermolecular interactions24. Two approaches were used to select the amino acids for
the mutation study. In one approach, all residues within a 3 Å distance of the bound OPEs
were mutated to alanine. The second approach more directly examined the effect of
charged residues in OPE binding. For the positively charged OPEs, anionic residues
(glutamic and aspartic acids) within 10 Å from the bound OPEs were mutated to alanine.
For the negatively charged OPE (2), cationic residues (lysine and arginine) within 10 Å
from the bound OPE were mutated to alanine. Mutations are specified by the wildtype
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amino acid, its location, and the mutant amino acid. For example, for the S35A mutant,
serine (S) at the 35 amino acid location was mutated to alanine (A). We then analyzed the
effects of these mutations on capsid-OPE binding in order to identify and confirm residue
“hot spots” that play important roles in binding strength. MD simulations of OPE-mutant
capsid complexes were carried out for 20 ns. MM-GBSA calculations were then
performed.
Representative RMSD plots for OPE-mutant capsid protein complexes and bound
OPEs were similar to those obtained for the wildtype complexes (Figure 2.5). The OPEmutant capsid complexes stabilized during 20 ns and the bound OPEs showed more
fluctuations where the large EO-DABCO-OPE1+ (5) moved the most, due to the change
in position of the large functional groups.
Table 2.2. MM-GBSA free energy component breakdowns for single mutations of
residues within 3 Å of S-OPE1+ (1) and OPE2+ (3). Each residue was mutated to
alanine. Change in the binding energies between wild type and mutant systems is also
shown.
ΔΔG = ΔG Mut − ΔG WT
Bind

OPE1+ / Capsid Complexes
Free
energy
ΔGVDW
ΔGEL
ΔGGB
ΔGSA
ΔGBind

Wild
Type
-40.2
-81.2
97.3
-6.10
-30.2

ΔΔG Bind

--

Bind

Bind

OPE2+ / Capsid Complexes

Mutants
S35A
-40.3
-78.4
103
-6.03
-22.0

S249A
-39.8
-75.4
100
-6.01
-21.1

P22A
-39.5
-80.7
105
-6.07
-21.8

D243A
-39.2
9.29
15.4
-5.83
-20.4

I33A
-39.6
-81.3
104
-6.07
-22.8

-8.17
± 1.8

-9.05
±1.8

-8.42
±1.6

-9.8
± 2.4

-7.38
± 1.3

Wild
Type
-55.10
-21.0
70.10
-7.21
-13.2
--

Mutants
E103
-53.0
119
-71.3
-6.71
-12.3

I163
-53.90
-20.40
68.7
-6.97
-12.6

-0.83
± 1.2

0.11
± 0.13

ΔGBind values for the binding between two cationic OPEs, the small S-OPE1+ (1)
and the large OPE-2 (3), with single mutants generated within a 3 Å distance from the
surface of the bound OPEs are summarized in Table 2.2. Whereas five amino acids were
in close proximity to the small S-OPE1+, only two were close to the larger OPE2+. Thus
as suspected, the smaller OPE binds closer to the capsid surface (grooves) than the larger
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OPEs, possibly due to reduced steric hindrance from the small OPE. Compared to the
wildtype capsid, the binding between the small S-OPE1+ (1) to single capsid mutants were
less energetically favorable, as shown by the less negative ΔGBind values of the mutants (
Mut
WT
ΔGBind
) compared to the ΔGBind value of the wildtype capsid ( ΔGBind
). Moreover, the

changes of ΔGBind values were large, where ΔΔGBind , as defined in Equation 2.6, were
around -8 kcal/mol, indicating that all amino acids in the binding site that are in close
proximity to the OPE are important to the binding.
(2.6)

WT
Mut
ΔΔGBind = ΔGBind
− ΔGBind

In contrast, a different trend was observed for the binding between the larger cationic
OPE2+ (3) and the two single mutants. The ΔΔGBind value for the E103A mutant was
slightly negative (-0.83 kcal/mol), whereas ΔΔGBind value for the I163A mutant was
slightly positive (0.11 kcal/mol). Thus, these two amino acids that are in close proximity
to the bound OPE do not significantly contribute to its binding energy. This finding is
consistent with the observation that only two amino acids were within 3 Å of this large
OPE and that the binding affinity was lowest for this OPE out of the five investigated
(Table 2.1 and Figure 2.7). The binding of OPE2+ (3) stems from the stronger Van der
Waals interaction between the longer OPE2+ backbone and the capsid surface (Figure 2.7).
Close range and specific interactions with amino acids do not appear to be important
contributions to OPE2+ binding.
To further investigate charge influence on OPE binding to the capsid surface, effects
of single versus multiple mutations on OPE binding affinity were explored (Figure 2.8).
For the wildtype system, the in vacuo electrostatic contribution of OPE2+ binding to capsid
was favorable (∆GEL < 0), while the solvation energy is unfavorable (∆GGB > 0) (Figure
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2.7 and black bars in Figure 2.8). However, when an anionic residue was mutated to an
uncharged residue (E103A) in the binding pocket, the two terms switched signs, where
∆GEL value became positive and ∆GGB value became negative. This effect was significantly
enhanced when five anionic residues were mutated, where ∆GGB became large and
negative, favoring binding, and ∆GEL became large and repulsive, disfavoring binding.
Contributions from ∆GVDW and ∆GSA remain largely unaffected by these mutations to the
charged residues.

changes

in

all

500

free

400

energy contributions
into

consideration,

the single anionic
residue substitution
resulted in a slightly
less stable complex (
ΔΔGBind =

-0.82

kcal/mol), indicating
modest electrostatic

Free energy (kcal/mol)

Taking
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E103A

300
200

E103A
E161A
E206A
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D502A

100
0
-100
-200
-300
-400

ΔGVDW

ΔGEL

ΔGGB
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Figure 2.8 Effect of single vs. multiple mutations on the free energy
components of OPE2+ binding to capsid protein. For each mutation,
anionic amino acid residues within 10 Å from the bound OPE were
mutated to alanine. The signs of the electrostatic contributions (DGEL
and DGGB) reversed with a single mutation. This effect was more
pronounced with 5 mutations were made. ΔΔGBind values for the
single and multiple mutants are -0.82 and -3.3 kcal/mol, respectively.

interaction contribution to OPE binding. In contrast, multiple substitutions of the anionic
residues resulted in a more stable OPE-capsid complex, with a ΔΔGBind value of 3.3
kcal/mol. Thus, consistent with conclusions drawn previously, close range and electrostatic
interactions with amino acids do not appear to be important contributions to OPE2+
binding to the capsid surface.
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To further examine the contributions from electrostatic interactions on the binding
between the OPEs and capsid protein, we performed the same multiple mutation study on
all OPEs. Residues that were oppositely charged compared to the OPEs within 10 Å from
the surface of the bound OPEs were mutated and contributions to binding energies were
also calculated. Similar to the OPE2+ (2) system (Figure 2.8), when charged residues
within the binding pocket were mutated to the neutral alanine, ∆GEL and ∆GGB values
switched signs compared to the wildtype system (Figure 2.7) and ∆GVDW and ∆GSA values
remain largely unaffected by the charged residue mutations. However, in contrast to
OPE2+, these mutations resulted in much less stable OPE-capsid complexes, where
ΔΔGBind values were all large and negative, except for the large OPE (4) where ΔΔGBind

value was slightly negative. Thus, for the two small OPEs (1 and 2), electrostatic
interactions with oppositely charged residues in the binding pocket significantly contribute
to their binding. For the larger OPEs with no side chains, 4 and 5, electrostatic interactions
with anionic residues showed varying effects. EO-TH-OPE1+ appears to be less dependent
on oppositely charged amino acids than EO-DABCO-OPE1+, which is significantly
affected as shown by a ΔΔGBind of -10 kcal/mol. Charge density on the ends of compound
5 may partially explain this effect. In addition, the flexibility of the pendant groups of EODABCO-OPE1+ supports this effect as they may wrap themselves around anionic residues
of the wild type capsid segment. However, when multiple mutations are introduced, the
favorable binding pocket composition is disrupted leading to a weakened overall binding
energy.
We performed more detailed single-molecule calculations using density functional
theory (DFT) at the B3LYP level of theory to understand how the conformational changes
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of OPEs may affect their binding properties. For the end-only OPEs, we generated a
conformational energy landscape (Figure 2.9A and 2.9B) as a function of the benzene ring

6-31G** level, to compare with
the

observed

sampling

seen

conformational
in

the

MD

360°

A.

Dihedral angle 1

dihedral angles, using DFT at the

to

interface.

the

0.08-0.1 eV
0.06-0.08
0.04-0.06
0.02-0.04
0-0.02

0°
0° Dihedral angle 2 360°

simulations when the OPEs are
bound

B.

C.

D.

capsid-solvent

Dihedral

angles

between the backbone rings were
rotated in 10 degree increments
to generate a potential energy

Figure 2.9 Potential energy profiles from DFT scans of
ethynylene dihedral angles for the two end only OPEs in
vacuum with overlayed dihedrals sampled during MD
simulations (A and B). Two SOPE1+ conformations taken
from MD and optimized at the 6-31g** level of theory (C
and D).

plot for each of the end-only OPEs (Compounds 1 and 4), shown in Figure 2.9. Rotational
energy barriers reached 0.1 eV at four regions on the contour surface. The barriers to
rotation for the compounds with terminal charge moieties are roughly 4 times thermal
energy at 300 K. These DFT conformational studies show that there are preferred dihedral
combinations in a vacuum environment that minimize the conformational potential energy.
Conversely, the structures obtained in the molecular dynamics simulations described above
show a wide range of conformational sampling that appears to overcome these barriers.
The scatterplot superimposed on the contours of the DFT scans show that when the EOOPEs are bound to the capsid surface, this conformational landscape is sampled quite
uniformly. This indicates that the environment provided by the protein capsid and
hydration of the solvent allow the OPEs to adopt multiple structures that would be difficult
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to achieve in vacuum (or a uniform dielectric). We also performed single point energy
calculations of two sample structures of S-OPE1+ from our MD trajectory to further
explore this effect in vacuum and in a dielectric continuum with a dielectric constant set to
that of water. It is interesting to note the fairly large difference in energy under each of
these conditions just for these conformations. The two sample structures are shown in
Figure 2.8C and 2.9D. The conformation in 2.9C experiences a net change of 5.55 eV in
energy when in vacuum compared to a dielectric, while conformation in 2.9D shows a
change of 5.32 eV (approximately 0.2 eV different). The energy difference in vacuum
between the two conformations is 1.62 eV compared to 1.39 eV in the dielectric medium,
which is significant. Nevertheless, both of these conformations are found when the OPE
binds to the capsid surface. As for the EO-OPEs, the conformations adopted by the bound
OPEs in our molecular dynamics simulations sample a wide range of the conformational
energy landscape of a single OPE molecule in a 20 ns timeframe. The many conformations
sampled by S-OPE1+ (1) in the MD simulations again signify the importance of the capsid
residues in allowing the OPEs to adopt a variety of positions during the binding process.
Furthermore, the electrostatic driving force significantly dominates the binding process
such that the conformational barriers are overcome.
2.4 CONCLUSIONS AND FUTURE DIRECTIONS
Multiple computational approaches were used to gain an understanding of the
molecular level interactions between conjugated oligomeric polyelectrolytes and the MS2
protein capsid. Docking calculations showed that OPEs exhibit strong and favorable sitepreferential binding to the capsid surface. The compounds bind in the grooves and
indentions along the outer capsid protein surface, where the hydrophobic backbones of the
OPEs interact with hydrophobic patches on the capsid surface. The charged side and end
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groups of OPEs may additionally interact with oppositely charged residues on the capsid
surface. Binding energies obtained from MM-GBSA calculations of OPE-capsid
complexes using all-atom MD simulations confirmed the strong nature of OPE-capsid
binding and showed that the smaller OPEs exhibited the strongest binding. The electrostatic
energy contributions to binding are strong for all the OPEs studied, but these are partially
counteracted by removing the charged OPE moieties from solution. This is particularly
important when looking at the binding of OPE2+, in comparison with the other four OPE
compounds. Since OPE2+ contains additional quaternary ammonium positive charge
groups, the free energy of binding to the capsid protein assembly is less favorable than the
smaller OPEs with two charge groups. This supports the observation that the compounds
with fewer PPE rings may be better suited as targets for the MS2 capsid. In general, the
van der Waals interactions contribute to the strong association of OPEs with the protein
coat in all cases. DFT single point calculations of two docked conformations of S-OPE1+
show large differences in the OPE conformational energies. Our MD simulations reveal
that these very large differences in OPE conformational energy do not affect interactions
with the capsid. In fact, the binding process for the end-only OPEs samples the gas phase
conformational landscape almost uniformly, indicating that the conformational energetics
of the backbone dihedrals is more than compensated by the intermolecular interactions that
dominate the binding energetics. Both the MD simulations and the DFT studies have
furthered our understanding of the mechanism of OPE-capsid binding. We have shown that
these compounds display strong binding to the MS2 coat that is consistent with observed
experimental results in which the viral capsid structures are significantly disrupted on
exposure to OPEs. This provides insight into the essential first step of a full mechanism
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that would describe the biocidal efficacy of OPEs against MS24. It is possible, for example,
that the OPEs may coat the capsid preventing attachment and infection of host cells. It is
also possible that the OPEs may enter the capsid through one of the capsid pores allowing
interaction with the genetic material of the virus. These topics are the basis for future
experimental and computational studies. The approach taken in this work is potentially also
useful for a study of OPEs as viable agents against other icosahedral based viruses that are
worldwide threats to health such as human papillomavirus (HPV), adenoviruses, and Zika
virus45-51.
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CHAPTER 3: Investigation of Fluorescence “Turn-On” Mechanisms of
Oligo p-Phenylene Ethynylenes Bound to Aβ Aggregates using
Molecular Dynamics Simulations
(This chapter will be submitted to ACS Chemical Neuroscience as Tye D. Martin,
Gabriella Brinkley, David G. Whitten, Eva Y. Chi, and Deborah G. Evans. Investigation
of Fluorescence “Turn-On” Mechanisms of Oligo p-Phenylene Ethynylenes Bound to Aβ
Aggregates using Molecular Dynamics Simulations)
ABSTRACT
Alzheimer’s Disease (AD) detection and treatment continues to be a critical
research area as an estimated 6 million cases of the disease were reported in 2018. Small,
bioactive molecules have shown promise as sensors for protein aggregates observed in two
pathological hallmarks found in AD: intraneuronal neurofibrillary tangles (NFTs) and
extracellular amyloid-beta (Aβ) plaques. Along with insoluble Aβ fibrils are heterogeneous
pre-fibrillar species which are known to be more toxic and cause disruption of neuronal
communication. A number of current sensors, such as Thioflavin T, are unable to pinpoint
these smaller aggregates, prompting the search for novel compounds with improved
detection. A class of conjugated oligomeric p-phenylene ethynylenes (OPEs) have shown
potential for signaling the presence of pre-fibrillar Aβ and also the ability to detect tau
aggregates which form NFTs. In this study, we seek to explore the nature of the binding
mechanism of OPEs to Aβ using classical all-atom molecular dynamics (MD) simulations.
Our simulations have revealed a number of OPE binding sites featuring hydrophobic and
charged amino acid residues on the surface of Aβ 5-mers and 24-mers. Binding energy
calculations have shown favorable energetic interactions for both anionic and cationic
OPEs. We have also observed self-assembly of OPEs during the simulated binding process
which could be one reason that OPEs displayed measurable fluorescence enhancement in
previous experimental studies.
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3.1 INTRODUCTION
Alzheimer’s disease (AD) is the most prominent neurodegenerative disease, with
5.5 million affected in the U.S. alone (in 2017). A projected 14.8 million will likely suffer
from AD by 20501. Diagnosis occurs well after progression of AD, often postmortem. In
addition, increased presence of two prominent hallmark lesions in either intraneuronal
(neurofibrillary tangles) or extracellular space (amyloid plaques) does not correlate with
symptom severity2.
At the microscopic level, amyloid plaques are large assemblies of misfolded
amyloid beta (Aβ) protein. Closer inspection at the molecular scale of Aβ fibrils reveals an
organized cross-β scaffold enriched with extensive regions of non-polar residues. Polar and
charged amino acids on these aggregates are aligned on the periphery. However, robust
detection of smaller Aβ oligomers and protofibrils, which are more neurotoxic, presents a
significant challenge due to their more heterogeneous structural nature3–9. Although Aβ
oligomers have the same distribution of residues that would still present favorable binding
sites, their conformations are more unstructured than fibrils10 which could be limiting for
a number of commonly used dyes.
Common fluorescent dyes with conjugated rod-like motifs such as thioflavin T
(ThT)5,11 and Congo Red (CR)12,13 have been successful in the detection of Aβ fibrils but
are limited by a single sensing mode often causing non-specific binding even to native
proteins14,15. Oligomeric p-phenylene ethynylenes (OPEs), a unique class of versatile,
multifunctioning compounds with applications including antimicrobial activity16–18 and
biomolecular sensors19–22, have shown promise as sensing agents of model protein
amyloids and more recently, disease-relevant Aβ, α-synuclein, and tau morphologies23–25.
These studies have resulted in selection of two promising OPE configurations (one to two
50

repeat units in size) with either cationic or anionic charged groups (for improved solubility
and charge attraction to Aβ) along the backbone, and ethyl ester termini (Fig. 3.1).
Published experimental work in our group has previously demonstrated how OPEs can be
used to detect Aβ fibrils and oligomers26. Several factors have been hypothesized to play a
role in the application of

Thioflavin T

Congo red

OPEs as fluorescent dyes,
including

+

hydrophobic

interactions, OPE J-dimer

OPE12-

OPE24+

formation, enhanced OPE
backbone

planarization,

and dequenching of the

Figure 3.1. Structures of Thioflavin T and Congo red
compared to OPEs.

ethyl ester end groups upon binding23–28. However, the molecular scale mechanism behind
the detection of these compounds is not completely understood.
A number of computational approaches including molecular dynamics (MD)
simulations and molecular docking have been used to investigate the properties of a
plethora of therapeutic and diagnostic bioactive molecules specific to AD29–37. Both
thioflavin T and Congo Red have been studied and reported to bind to Aβ protofibrils
favorably due to planarization of ring groups along the dye backbones29,30,34,35. Combined
molecular dynamics and quantum mechanics approaches have also been implemented to
characterize the binding mechanism of a series of oligo-thiophenes with different
functional groups and conjugation lengths to Aβ37,38. These studies provide a detailed
molecular scale view that, in conjunction with experimental evidence, bolsters
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understanding of the behavior of theranostic compounds relevant to neurodegenerative
disease.
In this study, we explore the interactions of OPE12- and OPE24+ with two Aβ
aggregates consisting of either 5 peptides (5-mer) or 24 peptides (24-mer) using atomistic,
explicit solvent MD simulations to elucidate the molecular-level details responsible for the
enhanced fluorescence observed upon binding of OPEs to Aβ aggregates. Specifically,
OPE binding sites appearing on the nanosecond time scale were analyzed to determine
amino acids promoting OPE12- Aβ association in addition to determining the extent of OPE
self-assembly or complexation on the Aβ surfaces. Hypotheses from previous experimental
studies of OPEs with amyloids were examined in detail in each of our simulations. We
confirmed OPE backbone planarization, electrostatic and non-polar energetic driving
forces in the binding process, and expulsion of water molecules (dequenching) during
binding, which support the Aβ aggregate specific detection of OPE12- and OPE24+ found
experimentally.
3.2 MATERIALS AND METHODS
3.2.1 Initial Structures
The initial coordinates of OPEs and Aβ aggregates were assembled with UCSF
Chimera39 by placing the OPEs a minimum of 10 Å from the fibril surfaces. The fibril
structure, 2LMN40 was obtained from the Protein Data Bank. In this work, we prepared
two different sizes of Aβ: a 5-mer and a 24-mer. The two different OPEs used, the anionic
OPE12- and longer, cationic OPE24+ were built using the GaussView 5 package41, and
geometry optimizations carried out with Gaussian 0941 following the approach used for
other OPEs in our previous work42. Specific system details are given in Table 3.1.
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Simulations were prepared using the AmberTools suite43. Parameters for simulating
the protein structures were obtained from the Amber14 force field44. The generalized
Amber Force Field (GAFF)45 was selected to parameterize the OPEs with partial atomic
charges derived using the Restrained Electrostatic Potential (RESP)46 approach via the
R.E.D. (Restrained Electrostatic potential charge Derive) server47. Each system was
solvated with explicit water molecules (following the TIP3P model)48 and counterions were
introduced to maintain charge neutrality.

Table 3.1 Details of simulated systems in this work
Net charge
System
# of OPEs per OPE
[OPE] mM
I-A
10
-2
8.5
I-B
10
4
8.5
II-A
12
-2
8.7
II-B
12
4
8.7

# of Aβ
peptides
5
5
24
24

# Replicates
3
3
1
1

3.2.2 Molecular Dynamics
The AMBER MD package was used to carry out all simulations49. The process of
producing these systems started with 1,000 steps of energy minimization holding the fibril
and OPEs fixed to allow settling of water molecules, followed by 2,500 steps of energy
minimization of the entire system. The system was then heated to 298 K. Following heating
of the system, NVT (constant number of molecules, volume, and temperature) equilibration
at a constant volume was carried out for 0.5 ns. Lastly, full production NPT (constant
number of molecules, pressure, and temperature) simulation was performed until 100 ns
was reached. Temperature was regulated using Langevin dynamics with a collision
frequency of 2 ps-1, and a new random seed was explicitly specified for each simulation
restart. A timestep of 2 fs was used. The nonbonded cutoff distance of 8 Å was used for
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short range effects with use of the Particle Mesh Ewald sum (PME) for long range
electrostatics. Computing resources provided by the Extreme Science and Engineering
Discovery Environment (XSEDE)50 via Comet of the San Diego Supercomputing Center
was used for MD simulations with GPU acceleration (with default single precision fixed
point or SPFP). After production runs, the trajectories were merged and processed using
PTRAJ and CPPTRAJ51, and visualized using UCSF Chimera39. Binding energy values
were determined using the molecular

OPE12-

OPE24+

mechanics Generalized Born Surface
Area (MM-GBSA) method52. The
implicit solvent (GB) model used here
was developed by Onufriev and

I-A

I-B

II-A

II-B

colleagues53. Additional details of
MM-GBSA as applied here can be
found in previous work42.
3.3 RESULTS AND DISCUSSION
3.3.1 OPEs readily bind to Aβ 5mers and protofibrils
Cationic and anionic OPEs are
observed to bind to the surface of both

Figure 3.2 Snapshots of bound and nonbound OPEs at 100 ns for oligomers (I-A and
I-B) and 24-mers (II-A and II-B). OPEs are
shown in stick representation with yellow and
blue spheres indicating anionic and cationic
charge groups, respectively.

the 5 Aβ peptide oligomer (systems I-A and I-B) and the 24 peptide protofibril (systems
II-A and II-B) in all-atom MD simulations on timescales of less than 100 ns. The OPEs
bind strongly and in general binding occurs with aggregation of OPEs on the surface.
Representative snapshots and trajectory labels for all systems are shown in Fig. 3.2 with
OPE pendant groups highlighted by yellow or blue spheres representing negative and
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positive charges, respectively. Corresponding snapshots for the second and third replica
trajectories of systems I-A and I-B are shown in Fig. 3.3. Aβ peptides are given in ribbon
representation with purple, orange, and gray denoting β-sheets, helices, and random coil,
respectively. Binding occurred predominantly during the first 20 ns (as determined by
contact point analysis between OPE and

OPE12-

OPE24+

I-A, trajectory 2

I-B, trajectory 2

I-A, trajectory 3

I-B, trajectory 3

Aβ – Fig. 3.4) with the majority of OPEs
remaining bound throughout the remainder
of the trajectories. Distances between any
atoms of the OPEs and Aβ residues within
4 Å were counted as contacts in this
approach. An OPE concentration of 10.2
mM (10 total OPEs and 2 OPEs per Aβ
peptide) was used in systems I-A and I-B,

Figure 3.3. Trajectory snapshots at 100 ns
of the anionic (left) and cationic (right)
OPEs bound to the 5-mer.

while a concentration of 8.74 mM was
used in systems II-A and II-B (a total of 12 OPEs each and 2 Aβ peptides per OPE). These
concentrations (103-fold greater than the experimental OPE concentrations on the μM
scale) were chosen in order to increase sampling of possible binding sites in addition to
allowing observation of any OPE self-assembly. This approach was successfully
implemented in prior studies by our group investigating curcumin-Aβ interactions54 and in
other similar computational studies including MD simulations of Aβ with ligands such as
Congo Red55.
In the case of the Aβ 5-mer, we observed 10, 8, and 4 OPEs (out of 10) bind in
three distinct trajectories with OPE12- (system I-A). System I-B showed 5, 6, and 7 (out of
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10) OPE24+ binding to the Aβ 5-mer in three replicas with OPE24+. Both positively and
negatively charged OPEs bind to the Aβ 5-mer (net charge of -5) as single molecules (net
of 7 out of 40 bound OPEs) and as complexes consisting of up to 5 OPEs (net of 31 out of
40 bound OPEs). OPE24+ predominantly formed dimers while OPE12- assembled to form
larger aggregates including tetramers and pentamers. A lower degree of aggregation of
OPE24+ in complexes could be the result of increased electrostatic repulsion since each
molecule has a net charge of +4. The smaller size of the 5-mer could also inhibit a portion
of the OPEs from binding. This is especially the case for the larger OPE24+ which is 33 Å
in length (the dimensions of the 5-mer are 19 x 38 x 49 Å).
In both system II-A and II-B, almost all (11 out of 12) of the OPEs bound to the
24-mer either as single molecules or complexes. The increase in total number of bound

# of contacts

OPEs on the 24-mer surface compared to the 5-mer is likely a result of the larger solvent
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Figure 3.4 Contact points between representative singly bound (left) and complexed
(right) OPE12- molecules in system II-A.
accessible surface area (33.1 nm2 for the 24-mer versus 10.2 nm2 for the 5-mer) accessible
to binding. Binding occurred frequently on the edges and ends of the 24-mer with few
OPEs found in the β-sheet regions. The OPEs complex predominantly as dimers with the
Aβ 24-mer, and these are formed either sequentially on the protein surface or after OPEs
self-assembled prior to binding. As with the simulations of the Aβ 5-mer, OPEs bound
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rapidly (before 20 ns) on the 24-mer, and in most cases for the entire 100 ns. Contact
analysis of system II-A showed some instances in which binding was delayed until after
the 50 ns time point due to OPE12- self-assembly occurring beforehand. Once bound, the
majority of OPEs remained in close contact with the 24-mer, however, a dimer in II-A
drifted away from the surface before binding again at 90 ns. We extended the simulation
time of this particular system to 200 ns and found that this OPE dimer remained bound to
the 24-mer thereafter.
3.3.2 OPE binding is influenced by both non-polar and charged residues
We explored the residue distribution surrounding the bound OPEs by counting the
number of amino acids within a 4 Å radius at the 100 ns time point. Fig. 3.5 shows the
resulting residue counts and relative percentages of four categories of amino acid (polar
uncharged, cationic, anionic, and non-polar) for singly bound and the innermost OPEs of
complexes bound to the Aβ 5-mer at 100 ns. Several trends in the residue composition at
binding sites for both OPE12- and OPE24+ are observed. OPE12- and OPE24+ binding sites
each have a significant fraction of contact points with non-polar residues on the 5-mer
(68% for OPE12- and 77% of OPE24+). Residue counts and percentages for the 24-mer
bound OPEs show a similar trend with non-polar amino acids being most prevalent at
binding sites. This is not surprising, as each Aβ aggregate features 70% non-polar residues
and the phenylene ethynylene backbones of the OPEs are hydrophobic. Most significant is
the difference in the charged residue ratios at the binding sites for OPE12- and OPE24+. In
the case of OPE12- the ratio of anionic to cationic residues within 4 Å is approximately 0.25
while the same ratio for the cationic OPE24+ is 3. This observed difference in charged
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residues at the binding sites is significant, since the ratio of anionic to cationic residues for
Aβ alone is 2.

B

OPE121
2
3
4
5
6
7
8
9

OPE24+
1
2
3
4
5
6
7
8
9
10
11

Bound OPE

Bound OPE

A

0

5

10
15
Number of amino acids

20

0

5
10
15
Number of amino acids

20

3% cationic
2.5% anionic

11% cationic

9% anionic
11% polar,
uncharged

18% polar,
uncharged
77% non-polar

68% non-polar

Figure 3.5 Number, percentages and types of amino acids (non-polar, polar
uncharged, anionic, and cationic) on the 5-mer within 4Å of each particular
bound OPE12- (A) or OPE24+ (B) along the y-axis at 100 ns.

Additional residue counts were carried out in 10 ns intervals after the mid-point of
the trajectories (50 ns) of system II-A for a complex-bound OPE12- and a single bound
OPE12- to compare the dynamics of the binding sites over time. As anticipated from
visualization along the trajectories, these data (Fig. 3.6) revealed the complexed OPE
binding site to be more stable (meaning little change between 10 ns increments) than the
site with a single bound OPE on the end of the 24-mer. On average, the number of cationic
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and non-polar residues within 4 Å of the complexed OPE changed by 1 to 2 amino acids
between time points (Fig. 3.6, bottom), compared to the single bound compound which
changed by up to 6 amino acids from 70 to 80 ns (Fig. 3.6, top). This behavior is also
indicative of the difference in relative binding sites as OPE assembly results in burial of
15

some OPEs underneath others, restricting movement (Fig. 3.6, bottom). In contrast, the
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This behavior can also be seen
in Fig. 3.4 where the contacts
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Figure 3.6 Number
residuespolar
over non-polar
time for a single
positive of
negative
bound OPE (top) and a complex-bound OPE (bottom)
over the final 50 ns of system II-A.

whereas contacts between a
complex bound OPE12- are
less dynamic.

In order to elucidate the energetic factors involved in OPE binding, we
implemented MM-GBSA calculations by analyzing the final 15 ns of each trajectory (to
ensure OPEs were completely bound). Binding energies, ΔGBind, for complexed OPEs were
obtained by treating the entire complex as a “ligand” bound to the protein receptor. The
resulting ΔGBind values in Table 3.2 are given for single and complexed OPEs bound to Aβ
5-mers (averages of all bound OPEs from three trajectories) and Aβ 24-mers (averages of
all bound OPEs in a single trajectory). There is a slight increase in magnitude of ΔGBind for
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OPE12- complexes over single OPEs for both the Aβ 5-mer and 24-mer. In contrast,
complexation of OPE24+ results in ΔGBind of essentially the same magnitude as ΔGBind for
single bound OPEs. It is likely that since OPE12- complexes as predominantly trimers,
tetramers and pentamers, (compared to OPE24+ which bind predominantly as dimers) the
binding effects of successive OPEs is cumulative.
Table 3.2. Average binding energies for singly bound or complexed OPEs in kcal/mol.

OPE1
Aβ oligomer
Aβ protofibril

single
-25.3 +/- 7.17
-31.7 +/- 6.56

2-

OPE2

complex
-36.0 +/- 13.6
-39.3 +/- 9.47

single
-36.6 +/- 7.69
-33.1 +/- 6.23

4+

complex
-34.2 +/- 10.1
-32.9 +/- 7.66

Energetic breakdowns for all bound OPEs were carried out (provided in Table 3.3)
to identify the factors that play a role in the binding strength. Interestingly, the electrostatic
components (ΔGEL) of the binding energies are always negative (favorable) in the case of
OPE24+ and mostly positive for OPE12-. Since the overall charges of both the Aβ 5-mer and
24-mer are negative, there is an unfavorable energetic effect associated with binding of the
anionic OPE12-. This is likely the reason for the resulting positive change in ΔGEL upon
binding. The generalized Born solvation term, ΔGGB, is opposite in sign to ΔGEL. This
means that introduction of the dielectric environment (a favorable process) screens the
electrostatic repulsion. However, when there are favorable electrostatic interactions
between OPE and Aβ then the dielectric disrupts the attraction. Nevertheless, the
competition between electrostatic and solvation components are always overcome by van
der Waals (VDW) effects and favorable reduction in solvent accessible surface area. The
result is a favorable ΔGBind for all bound OPE24+ and OPE12-. All of our binding energy
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calculations show a multitude of favorable sites on the Aβ 5-mers and 24-mers that promote
OPE association and complexation.

Table 3.3 Details of MM-GBSA calculations for single and complex bound
OPEs on the Aβ 5-mer and 24-mer.

OPE12-

OPE24+
Aβ 5-mer

Run

1

single

tetramer

pentamer

single

dimer

dimer

ΔGVDW
ΔGEL

-50.9
182.8

-57.9
-364.8

-52.2
361.2

-52.5
-598.3

-33.2
-782.8

-34.1
-791.8

ΔGGB

-161.9
-5.9

375.8
-8.7

-346.5
-6.4

615.3
-7.9

799.8
-4.6

807.6
-5.0

-35.9
single

-55.6
trimer

-43.8

-43.4
single

-20.8
dimer

-23.4
trimer

ΔGVDW
ΔGEL

-46.2
149.0

-41.3
-37.3

-59.5
-134.6

-70.1
-982.2

-43.7
-1066.7

ΔGGB

-126.1
-6.0

59.1
-5.8

157.0
-7.7

1003.4
-9.5

1085.1
-5.3

ΔGSURF
ΔGBind

2

ΔGSURF
ΔGBind

3

-29.2

-25.3

-44.8

-58.3

-30.6

ΔGVDW

single
-32.03

single
-22.88

dimer
-44.93

tetramer
-61.8

single
-30.0

dimer
-68.8

dimer
-36.0

dimer
-30.7

ΔGEL
ΔGGB

77.21
-57.75

98.18
-91.37

251.91
-229.83

336.8
-292.1

-253.1
266.0

-805.1
825.7

-881.7
898.2

-572.2
584.1

ΔGSURF

-4.00
-16.56

-3.48
-19.55

-5.96
-28.80

-9.5
-26.5

-4.4
-21.5

-8.2
-56.3

-4.3
-23.8

-4.1
-22.9

single
-45.7

single
-52.4

dimer
-37.7

tetramer
-77.3

single
-52.5

single
-40.7

dimer
-36.9

dimer
-64.1

ΔGGB

247.9
-231.8

521.7
-491.7

687.5
-665.4

1142.0
-1110.3

-1121.8
1149.3

-1433.0
1445.8

-2192.9
2208.1

-2340.3
2374.1

ΔGSA
ΔGBind

-6.5
-36.1

-5.0
-27.4

-4.9
-20.5

-12.6
-58.1

-7.1
-32.2

-6.0
-33.9

-5.6
-27.4

-8.1
-38.4

ΔGBind

Aβ 24-mer
Run
ΔGVDW
ΔGEL
1

3.3.3 OPE binding causes backbone restriction and reduction in OPE end group
hydration
Backbone planarization was investigated by measuring the pseudo-dihedral (pdihedral) angles between the phenyl ring groups of OPE12- free in solution, singly bound,
or in a bound complex. Fig. 3.7 shows the distribution of these p-dihedrals (from -180 to
180) over the last 50 ns of simulation time for system II-A indicated by red and black dots
(for each of the two p-dihedrals of OPE12-). There are clear differences in the restraint of
OPE backbone rotation (Fig. 3.7) depending on whether or not the molecule is bound. In
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the case of the free OPE in solution (top of Fig. 3.7) there is no preferential planarization
with both p-dihedrals sampling a range of values throughout the final 50 ns. Upon binding
as single molecules, the OPEs become more restrained as shown by the middle panel of
Fig. 3.7 where portions of the p-dihedral values are clustered together. Binding as single
molecules results in different extents of OPE backbone planarization to occur in which the
p-dihedral distribution is less clustered. Indeed, visualization of the trajectories shows
binding sites where the OPE backbone lies in close proximity to loop-regions on the 24mer surface with a more planar conformation, while other binding sites show portions of

+180°

-180°
Single bound
OPE

+180°

OPE bound in
complex

+180°

-180°

Pseudo-dihedral angle

+180°

Free OPE

+90°

0°

100 ns

planar

-90°

-180°

50 ns

planar

planar

-180°

Figure 3.7 Pseudo-dihedrals between each pair of phenyl rings (shown in red and
black dots) for last 50 ns of free (top), singly bound (middle), and complexed OPE12(bottom) bound to large 24-mer. Schematic showing atoms chosen for dihedral
analysis (blue circles) and corresponding angles sampled are given on the right.
the molecule extending away from the protein (which would allow more unrestricted
rotation). Conversely, when the OPEs are bound in a complex, especially with more than
two molecules, there is a significant restraint of backbone rotation resulting in
planarization. This pattern is observed in the lowest panel of Fig. 3.7 in which the OPEs
bound in tetramers exhibit significant clustering of p-dihedrals near 0 degrees. We

62

performed similar analysis of a free and complex-bound OPE24+ (data not shown) on the
24-mer and found that backbone restriction did occur upon binding, albeit to a lesser extent
than OPE12-. As OPE24+ only formed dimers in our simulations, the restriction in pdihedrals is less pronounced compared to OPE12-. This can be understood from previous
quantum mechanics studies of OPE planarization in our group27. The delocalization length
for OPEs is approximately 3 phenyl rings long. The rotational barriers about the p-dihedrals
for OPE24+ are therefore lower than for OPE12-. This means full planarization of the fivering backbone of OPE24+ is unlikely.
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analysis, we also determined the
overall planarity of OPE12- similar to
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In addition to the p-dihedral2.5

the approach used by the Lindgren
56

Single
bound
OPE

Free
OPE

planarity of the molecule. The total
planarity, P, was determined by
summing over all dihedrals for each
time point (after binding occurred) as
given by Equation 4.1

OPE
bound in
complex

Figure 3.8 Box and whisker profiles showing
distribution of planarity values for free (blue),
singly bound (orange), and complexed (gray)
OPE12- on 24-mer with a value of 2 indicating
a fully planar backbone.

.

(1) (4.1)

In order to compare the distribution of P between distinct OPEs, box and whisker plots
were generated, with a value of 2 indicating a fully planar backbone and 0 indicating a
backbone completely out of plane. Fig. 3.8 compares the distribution of three sets of P for
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free, single bound, and complex bound OPE12-. The complex-bound OPE is in a more
planar conformation (with most of the data falling between P values of 1.5 and 2) compared
to a single bound molecule with P values predominantly between 1 and 1.5. By
comparison, the free OPE in solution is less planar with the majority of P values lying
between 0.5 and 1.5. Fig. 3.9 shows

2.5

2.5

additional plots for other Aβ bound
2-

2

2

OPE1 compared to a free (unbound)
1.5

1.5

these cases but the very obvious1

P-value

OPE12-. Similar trends are observed in

differences in planarity between single
0.5

1

0.5

and complex bound OPEs is less
0

0

pronounced in these trajectories. This is
largely due to the variability in the
binding sites of the OPEs, each resulting
in distinct and unique patterns of

Free
OPEs

Single bound
OPEs

OPEs bound in
complex

Figure 3.9 Box and whisker profiles showing
additional planarity values for free, single, and
complex bound OPE12- on the 24-mer with a
value of 2 indicating a fully planar backbone.

backbone planarization. Certain OPE binding sites and aggregations result in the OPEs
binding more tightly to the surface of the protein, and in conformations that restrict
rotations around the hydrocarbon long axis of the molecule.
Fig. 3.10 displays the total number of water molecules over time for free, singly
bound, and complexed OPE12- in system II-A. Representative snapshots (green boxes in
Fig. 3.10) are given for the 0 and 100 ns time points. In the case of the free OPE, the water
molecules surrounding the end groups remains stable at approximately 15 molecules. Upon
binding as a single molecule on the end of the 24-mer, one particular OPE12- shows a slight
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decrease in number of water molecules. This particular binding site does still allow the
ethyl termini to be partially exposed to the water environment. Binding in a complex
reduces the number of waters around the end groups further as seen by the rapid decline
during the first 10 ns of simulation time (Fig. 3.10, lowest plot).
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Figure 3.10 Number of water molecules over time
for free (blue), single bound (orange), and
complex-bound (grey) OPE12- in system II-A.
Green insets show trajectory snapshots at the
beginning (0 ns) and end (100 ns) of the
trajectories with water molecules within 3.4 Å of
ethyl ester termini in red and white spheres.
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summarizes these findings by plotting average ΔGVDW contributions for dimers, trimers,
and tetramers of OPE12-, OPE24+, and curcumin. The ΔGVDW components for OPE12- and
OPE24+ are more negative (favorable) likely because of increased p electron polarization
along the length of the molecules due to the number of aromatic ring groups (3-5) compared
to 2 for curcumin.
Average ΔGBind of OPE12-, OPE24+, and curcumin are shown in Fig. 3.11 in addition
to literature values for ThT29, BTA-1 (a neutral ThT analog)29, and CR30. We previously
calculated total binding energies of -12 to -30 kcal/mol for curcumin complexes binding to
an Aβ 24-mer which are lower that ΔGBind of both OPE12- and OPE24+ on average. ThT,
which is cationic, does bind favorably to Aβ with reported values of -5.3 kcal/mol but less
so than BTA-1 (-16.3 kcal/mol). The negatively charged CR has shown ΔGBind of up to 22.8 kcal/mol which is lower than the binding energies for OPE12- and OPE24+. It is evident
that the conjugated phenylene ethynylene backbone of the OPEs enhances binding, as
OPE12- and OPE24+ both bind more favorably than ThT and its derivatives. In addition,
introduction of charge moieties and their relative location influence the binding sites and
binding constants. The OPEs have two charge groups per subunit attached to alkyl “arms”
positioned away from the backbone that provide added flexibility, which in turn
accommodates stronger binding to sites with oppositely charged amino acid residues (Fig.
3.12). By comparison both CR and ThT have charge groups attached directly to their
aromatic ring groups. This can potentially cause weaker binding due to the constraint that
the electrostatic groups are closer to the backbone and not tethered on the ends of relatively
long, flexible sidechains. Based on the data from our simulations we conclude that the OPE
binding mechanism is comprised of two distinct processes: (i) electrostatic interactions of
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oppositely charged amino acids on the OPE and protein residues are the primary initiating
factor for OPE12- Aβ association and (ii) van der Waals (and hydrophobic) interactions of
the OPE backbone with the protein surface result in strong binding of the OPEs which
remain bound over hundreds of nanoseconds.
Another result from our simulations that explains the OPE12- - Aβ sensing efficacy
is due to two features resulting from the strong hydrophobic interactions between OPEs

simulations for both OPE12- and
OPE24+especially in cases where

peptides and other bound OPEs. This
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Figure-403.11 ΔGVDW components for dimers
(black), trimers (red), and tetramers (green) of
OPEs and curcumin (top)54. Comparison of total
ΔGBind of OPEs, curcumin, CR, and ThT based
compounds (bottom)29,30.

compounds due to the “segment chromophores” or π-conjugation length27. Other MD
simulations62 have been used in conjunction with experimental work by Lindgren and
coworkers to explore similar spectral properties including backbone planarity of a series of
oligothiophenes and the implications in binding to insulin fibrils.
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Increased fluorescence due to dequenching of OPE ethyl ester end groups has been
hypothesized from experimental studies on OPE-amyloid interactions25. This results in
water molecules being crowded out from the OPE termini upon binding. Earlier OPE work
has shown dequenching effects when the molecules are in more non-polar environments
such as methanol63 and when complexing with detergents such as sodium dodecyl sulfate
(SDS)28. This phenomenon is clearly observed in our MD simulations which show
decreasing amounts of water molecules within the first solvation shell (3.4 Å) of the bound
OPE12- end groups, especially in the case of complex bound OPEs where the average
number of waters drop as much as 10 molecules per OPE after the first 10 ns of simulation
time.
The data from this work also enhances our understanding of the different energetic
components involved with OPE- Aβ binding interactions. ΔGBind values (provided by
previous experimental work)26 are approximately
-10 kcal/mol for OPE12- and OPE24+ both of
which are smaller in magnitude than ΔGBind from
the simulations in this study (approximately -30
kcal/mol). Similar differences in experimental
ΔGBind and MD values obtained through MMGBSA are well-documented64. For instance,
differences of up to 30 kcal/mol64 between
known experimental and simulated ΔGBind of
ligands with α-thrombin proteins have been

Figure 3.12 OPE12- (top) binding to
a cationic rich site (blue) and
OPE24+ (bottom) binding to sites
enriched with anionic residues.
OPE charge groups are shown in
orange spheres.

reported. These differences could also be due to the fact that experimental binding was
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explored in presence of either Tris or phosphate buffer (to promote distinct fibril
morphologies) while our MM-GBSA simulations take place within implicit solvent with a
salt concentration of 100 mM. The result is decreased screening of the interactions between
OPEs and Aβ in our simulations and therefore more favorable ΔGBind. Additional reasons
for this could also be due to differences in fibril morphology and exclusion of entropic
effects in our calculations. Entropy contributions calculated through normal mode analysis
are often absent in MM-GBSA studies when comparing relative binding behavior between
similar molecules (i.e. OPE12- and OPE24+). However, a recent study on ThT and a potential
PET probe, AZD218434, did include this effect and found that ΔGBind of ThT to Aβ 5-mers
became less negative (unfavorable) by as much as 24 kcal/mol leading to total ΔGBind of 4.7 kcal/mol for one particular binding site. It is interesting to note the difference between
ΔGBind of OPE12- and OPE24+ obtained experimentally (-8.7 +/- 0.09 versus -9.6 +/- 0.08 in
tris) is also found in our MM-GBSA estimates for singly-bound molecules (-28.5 +/- 6.8
and -34.8 +/- 6.9 kcal/mol, respectively).
3.4 CONCLUSIONS AND FUTURE DIRECTIONS
Our nanosecond scale simulations provide direct molecular level insight into the
mechanism of OPE- Aβ binding. In particular we have found: (i) Both anionic and cationic
OPEs complex on Aβ 5-mers and 24-mers in a staggered fashion with evidence of bricktype stacking (characteristic of J-dimerization)65 where the charge groups are positioned
away from one another. (ii) Binding sites of the OPEs are dependent on oppositely charged
amino acids, with a clear preference for the anionic OPE12- to bind in sites enriched with
positively charged residues and vice versa for OPE24+. In addition, binding site analysis
and ΔGBind decomposition show non-polar residues are also important in the binding
process based on hydrophobic interactions. (iii) ΔGBind values from MM-GBSA
69

calculations show that OPE complexation is energetically favorable compared to binding
as single molecules. Our calculated binding energies of both OPEs are more favorable than
other well-known dyes used to detect Aβ aggregates including thioflavin T and Congo Red.
(iv) OPE complexation on the Aβ 5-mers and 24-mer results in restriction of rotation and
increased planarity of their phenylene ethynylene backbones, especially in the case of OPE
tetramers. (v) Desolvation of the ethyl ester end termini of the OPEs occurs readily upon
binding as complexes.
The molecular level reasons behind how and why OPEs bind so effectively to Aβ
are a combination of hydrophobic effects, electrostatic interactions, and OPE
complexation. Planarization of the phenyl moieties of the OPEs has been hypothesized
based on experimental and quantum level studies of their photophysical properties
stemming from increase of conjugation length63. Our simulations clearly support this
finding as complexed OPEs adopt a flattened conformation. Experimentally, OPEs display
fluorescent signatures when bound to biological assemblies with characteristics of Jaggregation including bathochromic absorbance shifts and enhancement of fluorescence
yields23,25,26. Our MD simulations agree with this, as OPE12- and OPE24+ both complex on
the 5-mer and 24-mer surfaces with their backbones in a staggered arrangement.
Experimental studies of OPE detection of amyloids have also demonstrated drastic changes
in fluorescence due to subtle structural modifications of the OPEs, specifically addition of
ethyl ester pendant termini. Prior to this study, it was posited that dequenching of OPE end
groups due to binding caused additional fluorescence “turn-on” enhancement. Our
simulations have helped us understand this behavior, with expulsion of water molecules
from the first solvation shell following the complexation of OPEs on the Aβ 5-mer and 24-
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mer surfaces. These phenomena all work in concert to promote OPE sensing of fibrillar Aβ
and smaller, toxic aggregates. Similar mechanisms likely occur when OPEs bind to other
disease-related protein assemblies, including tau fibrils in AD α-synuclein found in PD.
The multiple sensing modalities provided by these compounds make them promising
agents for screening of AD aggregates with more robustness than currently available dyes.
In future studies, we plan to extend these simulations to microsecond time scales
via allocation time on the Anton 2 supercomputer66 to determine factors including impact
on Aβ fibril structure (shown in CG studies by the Hall group to occur at this time scale)67
and persistence of OPE binding stability. We will also carry out partition coefficient
calculations, which we have successfully determined for curcumin molecules, to aid in
further optimization of OPE structures along with experimental work in order to better
understand the capability of the molecules to cross the blood brain barrier (BBB). This is
a critical step as experimental testing of OPE detection in animal models is pursued.
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CHAPTER 4: A Computational Study of the Driving Forces and
Dynamics of Curcumin Binding to Amyloid-b Protofibrils
(Most of this chapter has been published in Journal of Physical Chemistry B and appears
as Tye D. Martin, Angelina J. Malagodi, Eva Y. Chi, and Deborah G. Evans.
Computational Study of the Driving Forces and Dynamics of Curcumin Binding to
Amyloid‐β Protofibrils, J Phys Chem B, 123: 551-560, 2018.)
ABSTRACT
Oligomeric aggregates of the amyloid-β (Aβ) peptide are believed to be the primary
toxic species that initiates events leading to neurodegeneration and cognitive decline in
Alzheimer’s disease (AD). Small molecules that interfere with Aβ aggregation and/or
neurotoxicity are being investigated as potential therapeutics for AD, including naturally
occurring polyphenols. We have recently shown that curcumin exerts a neuroprotective
effect against Aβ40 induced toxicity on cultured neuronal cells through two possible
concerted pathways – ameliorating Aβ oligomer-induced toxicity and inducing the
formation of nontoxic Aβ oligomers – both of which involve curcumin binding to Aβ
oligomers. To gain molecular level insights into curcumin’s interaction with Aβ oligomers,
we use all-atom molecular dynamics (MD) simulations to study the dynamics and
energetics of curcumin binding to an Aβ protofibril composed of 24 peptides. Our results
show that curcumin binds to specific hydrophobic sites on the protofibril surface and that
binding is generally associated with the concomitant complexation of curcumin into
dimers, trimers, or tetramers. Curcumin also binds to the protofibril growth axis ends, but
without complexation. Analysis of the energetics of the binding process revealed that
curcumin complexation contributes in an additive fashion to curcumin - Ab protofibril
interactions. Favorable curcumin-protofibril binding is driven by a combination of
hydrophobic interactions, curcumin self-aggregation, and solvation effects. These
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interactions are likely critical in reducing Aβ oligomer toxicity and inducing the growth of
the protofibrils into “off-pathway” wormlike fibrils observed experimentally.
4.1 INTRODUCTION
Alzheimer's Disease (AD) is the leading cause of dementia in aging populations,
affecting over 5.5 million people in the U.S. and new cases are diagnosed at an alarming
rate of 1 per minute.1 By 2050, there will be a new diagnosis of AD or a similar
neurodegenerative disease every 33 seconds. As the number AD cases rises, so will the
economic impact. In 2018 the estimated costs related to AD and other dementias is $259
billion.1 These factors emphasize the critical need for developing treatments that reduce
symptoms or reverse cognitive dysfunction.
Pathological hallmarks linked to the loss of brain function in AD are intracellular
and extracellular lesions that disrupt neuronal function and communication. Intraneuronal
neurofibrillary tangles (NFTs) composed of fibrillar aggregates of the tau protein block
neuronal transport, while extracellular amyloid plaques composed of fibrillar aggregates
of the amyloid-β (Aβ) peptide disrupt neuronal communication.2–4 Although these fibrillar
aggregates are prominent pathological features,3,5 smaller pre-fibrillar oligomeric
aggregates of Aβ and tau have been found to be more toxic than fibrils.6,7 In particular, Aβ
oligomers have been found to exert a number of inhibitory effects and are the focus of
many studies to resolve the mechanisms of oligomer formation and toxicity. They are also
a primary target for discovery of new methods to disrupt the pathology of AD and related
diseases involving aggregation of misfolded proteins.8–12
One class of aromatic compounds, flavonoids, has garnered interest in the
prevention and treatment of AD and other neurodegenerative diseases. Flavonoids are plant
secondary metabolites and are a subclass of the naturally-occurring polyphenols and have
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long been known for their multi-faceted pharmacological properties, including antiinflammatory, anti-oxidant, anti-tumorigenic, anti-cancer, anti-microbial, and antivascular properties.13–16 Moreover, the beneficial effects of flavonoids and polyphenols in
neurodegenerative diseases, including AD, have been documented. Curcumin, a nonflavonoid polyphenol found in the spice turmeric, has been found to improve learning and
memory and reduced Aβ-induced impairments in AD animal models and ameliorated Aβinduced toxicity in cell cultures.17–22 However, the mechanism of curcumin’s protective
effect remains to be elucidated.10,23–25
The neuroprotective effect of curcumin could in part be due to its anti-oxidative
and anti-inflammatory properties. Many studies have also examined how curcumin directly
affects Aβ aggregation and toxicity. Studies in the past have concluded that curcumin
inhibits fibril formation and destabilizes preformed fibrils.26–28 However, other studies
have found that curcumin had either no effect or enhanced fibril formation.20,29 We have
shown that curcumin did not

Native,
disordered
monomers

impede fibril growth of Aβ40 but

On pathway toxic
oligomers

100 nm
Fibrils

instead induced the growth of
“off-pathway” fibrils with a

Curcumin

Off pathway
nontoxic oligomers

Divergent
fibrils

Figure 4.1. Schematic of fibril formation pathways in the
presence and absence of curcumin. The natively unfolded
Aβ40 samples a wide range of conformations (left),
misfolds and self-assembles into b-sheet enriched
oligomers (middle), and eventually form fibrils (right).
Curcumin has been shown to promote the formation of less
toxic oligomers and curly fibrils (lower right) compared to
straight fibrils (upper right).

wormlike appearance (Figure
4.1).30 Additionally, curcumin
ameliorated the toxicity of Ab
oligomers formed early in the
aggregation

process

and

promoted the formation of non-toxic oligomers. We hypothesized that these effects, as well
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as those observed by others, could be caused by curcumin binding to Ab oligomers that
concomitantly blocked toxicity and altered aggregation (Figure 4.1). However, further
investigation is needed to gain a molecular-level understanding of the role curcumin plays
in modulating Ab fibril growth and toxicity.
Interactions of small organic molecules with amyloid aggregates have been studied
with MD simulations to resolve molecular level details of binding sites, binding
interactions, and binding energies.31–40 The Shea group performed MD simulations on the
binding of Congo red (CR) to Aβ protofibrils in which the CR was observed to bind to
lysine-rich sites.41 The Bevan group studied morin interactions with Aβ42 to determine
the potential mechanisms of fibril growth disruption.32 Morin was found to form hydrogen
bonds on the ends of the protofibrils and disrupt subsequent monomer addition. Potential
binding mechanisms of curcumin to protein aggregates including tau and Aβ have also
been studied using coarse-grained and MD simulations.8,42–44 The Hall group used a
coarse-grained approach to explore the impact of curcumin and other flavonoids on
protofibril structure and growth by peptide addition.44 Masunov and Berhanu simulated
fibrils formed from a 6-amino acid tau peptide, VQIVYK, complexed with curcumin,
exifone, or myricetin. Their results showed binding energies of curcumin are more
favorable based on molecular mechanics generalized Born surface area (MM-GBSA)
analyses.33 While there have been computational studies on binding of curcumin to Aβ
based on docking and short (up to 20 ns) simulations,42,43 there has not yet to our knowledge
been an all atom MD study to explore de novo curcumin binding to large Aβ protofibrils at
longer time scales. Moreover, curcumin self-assembly and its contribution to interactions
with Aβ has not been examined thoroughly.
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In this computational study, we use all-atom solvent explicit MD simulations to
investigate the interactions between curcumin and an Aβ protofibril to gain detailed
information of the binding sites and the dynamics and energetics of curcumin-Ab
interactions. Combining these simulation results with closely related experimental findings
will reveal insights into the curcumin-Aβ interactions that have been shown to reduce Ab
oligomer toxicity and cause the formation of off-pathway worm-like fibrils.30 Using a
structural model of an Aβ40 fibril with two-fold symmetry45 as a starting point, an Aβ
protofibril with 24 monomers was generated and curcumin molecules were positioned
around the protofibril. MD simulations were then run to explore curcumin binding. Our
results show that curcumin readily binds to the protofibril in a distinct pattern and binds
either as complexes (2-4 curcumin molecules) or as single molecules. Characteristics of
the binding sites and binding energies have been analyzed to assess the driving force and
dynamics of curcumin binding to Ab protofibrils. We describe our findings in the context
of other MD-based studies specifically comparing binding energetics and locations with
curcumin and other small molecules.
4.2 MATERIALS AND METHODS
4.2.1 Structure Preparation
Initial coordinates for the Aβ40 protofibril used in all simulations were obtained
from the Protein Data Bank (PDB ID 2LMN) with the monomer sequence shown in Figure
4.2a (residues 9-4045). Additional monomers were added to the ends of the protofibril until
each fold contained 12 monomers (24 total) (Figure 4.2b). Curcumin molecules were built
using the GaussView software package (Figure 4.2c).46 Geometry optimization of
curcumin was performed at the HF/6-31G* level prior to positioning the molecules around

87

the fibril. Each system listed in Table 4.1 was created using UCSF Chimera and later
solvated with the addition of counterions using AmberTools.47,48
4.2.2 Simulated Systems
To explore curcumin-protofibril interactions, explicit solvent all-atom molecular
dynamics (MD) simulations on 7 systems with varying amounts (up to 0.08 M) of curcumin
in the presence or absence of an Aβ40
protofibril (Table 4.1) were performed. For

a

N-terminus

b

Langmuir

most systems, 3 or 4 replicate simulations
Scheme 1. Schematics of Curcumin (A), Lipids (B), a Langmuir Trough Containing a Wilhelmy Plate and a L
for Protein Insertion Assays (C), and a Dye-Loaded Porous Silica Microsphere Covered with a Lipid Bilayer
Membrane Disruption Assay (D)
C-terminus

were run. The curcumin concentrations are

c
higher than that used in experimental work
(on the μM scale) in order to observe
binding at timescales reachable by all-atom
MD. In Systems 1, 2, 3, and 5, a preequilibrated protofibril was used as a

Curcumin

Figure 4.2. (a) Sequence of a Aβ(9-40)
hairpin peptide monomer. (b) Aβ
protofibril containing 24 monomers used
in this study prior to equilibration (initial
coordinates obtained from Tycko et. al.)45
(c) Curcumin structure (enol form).

starting point. In Systems 1, 2, and 3, either
1 or 12 curcumin molecules were placed 10 Å from the protofibril surface (b-sheet and
hairpin regions) and growth axis ends. Systems 4 and 5 were prepared by taking the initial
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Table 4.1
1. Summary
performed
# of
# of
curcumin
protofibril solvent curcumin molarity
System present molecules molecules
(M)

total
atoms

simulation
length (ns)

box
dimensions
(Å)

# of
trajectories

solvent

1

yes

24,662

1

0.02

85,504

20

105 x 80 x 113

3

water

2

yes

25,810

1

0.02

88,948

20

103 x 85 x 113

3

water

3

yes

31,866

12

0.02

107,633

100

111 x 97 x 117

2

water

4

no

37,387

12

0.02

111,597

45

107 x 98 x 116

1

water

5

yes

24,707

0

0

85,593

100

106 x 83 x 112

1

water

6

no

2,376

3

0.08

7,269

20

41 x 41 x 37

3

water

7

no

2,040

3

0.08

6,261

20

41 x 41 x 37

3

methanol

4.2.3 Molecular Dynamics
Classical all-atom MD was employed to explore curcumin-fibril interactions with
explicit solvent using the AMBER15.0 environment.48 Periodic boundary conditions
(PBC) were used and the cutoff value for non-bonded interactions was set to 8 Å. Bond
interactions involving hydrogen atoms were excluded. For all systems, a minimum of 1000
cycles of steepest descent followed by 500 cycles of conjugate gradient minimization were
carried out. Two heating cycles were used to bring the temperature to 300 K with the solute
fixed in the first heating stage and released in the second. Constant number of molecules,
pressure, and temperature (NPT) equilibration runs were allowed to reach 5 ns after the
heating stage. Full NPT production runs were then performed for the times shown in Table
4.1. Pressure was set to a 1 atm over 50 ps in all simulations. For temperature control, the
Langevin thermostat was used with hydrogen coupling and a collision frequency of 2. All
visualization of trajectories was completed using the UCSF Chimera program and
trajectory processing was carried out using AmberTools.49 Clustering analysis on the
resulting trajectories was performed with UCSF Chimera.47,50 The Amber ff99SB force
field was used to represent the Aβ fibril with curcumin parameters obtained using the
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generalized amber force field (GAFF).51,52 All MD simulations were carried out on the
XSEDE53 Comet cluster at the San Diego Supercomputer Center which offers GPU
acceleration through the Amber MD software package.
4.2.4 Calculations of Free Energies of Binding
All binding energy calculations were performed using the molecular mechanics
generalized Born surface area (MM-GBSA) method54 as provided by AmberTools.49 This
approach allows binding energy (∆GBind) to be calculated as:
(4.1)

ΔGBind = ΔGMM + ΔGGBSA

∆GBind is comprised of ∆GMM, which represents gas phase interactions between a ligand
and receptor, and ∆GGBSA, which represents solvent contributions incorporated into the
implicit solvent term with polar and non-polar effects. This MM-GBSA approach was
previously used to approximate ∆GBind values between a class of conjugated polyelectrolyte
antiviral compounds and the model virus MS2.54
∆GBind values of curcumin-protofibril binding were determined in order to explore
two potential mechanistic pathways of curcumin aggregation on the protofibril surface. For
the first approach, the entire curcumin aggregate, from 2 to 4 molecules, was selected as a
bound ligand on the protofibril substrate. The second approach calculated ∆GBind between
the outermost curcumin molecule of the curcumin aggregate to the protofibril and
innermost curcumin. In other words, this approach models subsequent addition of a single
curcumin to a bound curcumin complex on the protofibril (see Table 4.2 schematics). MMGBSA was then used to calculate ∆GBind of curcumin dimers to estimate the contribution
of curcumin complexation (or self-assembly) to the binding of the curcumin complex to
protofibril.
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4.3 RESULTS AND DISCUSSION
4.3.1 Curcumin binding pattern and locations
Each Ab monomer contains two phenylalanine and one tyrosine. When assembled
into a protofibril, these aromatic residues align in rows along its outer surface (excluding
ends), which could be potential binding sites for curcumin through hydrophobic and p-p
interactions. In Systems 1 and 2 (Table 4.1), a curcumin molecule was placed 10 Å away
from either phenylalanine or tyrosine rich locations. After a short time, 20 ns post energy
minimization and equilibration, the curcumin becomes bound to the phenylalanine rich
sites (green) and remains in the bound position (within 5 Å from the residues) in all three
trajectories of System 1. Conversely, curcumin placed near a tyrosine-rich location (blue)
did not result in a stable bound conformation in the three trajectories (System 2, data not
shown). In Trajectory 3, curcumin moved toward the simulation cell boundary 12 Å away.
Curcumin thus favorably interacts with phenylalanine residues on the fibril surface that
leads to stable binding, but exhibited less favorable binding with tyrosine residues.
Next, a larger system with 12 curcumin molecules surrounding the protofibril was
prepared to improve sampling (System 3); the time scale was also extended to 100 ns. A
series of snapshots along one trajectory of System 3 (Figure 4.3) showed that curcumin
bound rapidly to the protofibril surface and formed complexes (at around 20 ns) that were
stable for up to 100 ns. Complexation of curcumin could be mediated by p-p stacking since
the phenyl rings were aligned in most of the complexes. Curcumin molecules placed close
to the ends of the protofibril also became bound to the growth axis of the protofibril early
in the trajectory. As shown by snapshots in Figures 3, these curcumins partially inserted
into the ends of the fibril, but as single molecules. Similar behavior was observed in the
second trajectory of this system. After approximately 40 ns, the curcumin positions
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stabilized and were grouped into a single cluster indicating small changes in position as
compared to the beginning of the simulations where a wide range of structural clusters were
observed.
To more closely examine curcumin binding sites on the protofibril surface,
residues within 5 Å of the four bound curcumin complexes (A, B, C, and D) obtained from
Trajectories I and II of System 3 were analyzed in detail (Figure 4.4A). For Trajectory I,
0 ns

20 ns

40 ns

60 ns

80 ns

100 ns

Figure 4.3. Simulation snapshots of Aβ40 protofibril with 12 curcumin molecules over
100 ns. Curcumin complex readily with one another and all appear bound at various
regions of the fibril by the end of the trajectory.

Complex I-A is bound to a site with hydrophobic valine (red) and phenylalanine (green)
residues. Interestingly, the complex is bound at an angle as opposed to lying flat along the
benzyl ring groups of the phenylalanine. Complex I-B is a curcumin trimer bound at the
corner of the protofibril (Figure 4.4A). This site displays a more heterogeneous population
of amino acids including tyrosine (blue), histidine (gray), and glutamic acid (yellow), along
with valine (red). The Complex I-C binding site is similar to that of the Complex I-A
binding site: rich in phenylalanine (green) and valine (red). However, this complex makes
additional contacts with the protofibril surface including the bend or turn area. Complex ID is a curcumin dimer bound to serine (orange) and asparagine (magenta) residues.
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For Trajectory II, Complexes II-A, II-B, and II-C associated similarly compared to
those in Trajectory I (Figure 4.4b). Complex II-A shows a curcumin dimer bound to the
phenylalanine (green) and valine (red) rich region while II-B and II-C show a tetramer and
a dimer, respectively, bound to heterogeneous sites with tyrosine (blue), valine (red), lysine
(cyan), glutamic acid (yellow), and histidine (gray). Complex II-D is a curcumin dimer
aligned with tyrosine residues along the fibril edge. Compared to the other complexes, the
curcumin molecules in Complex II-D appear side by side and are bound closer to the
tyrosine residues than in Complex I-D.
In order to determine the most common amino acids in the vicinity of bound
curcumin, we analyzed the number of contacts within 5 Å (hydrogens excluded) for System
3 trajectories (shown for Complex I-A in Figure 4.5a) and found that the hydrophobic
phenylalanine, valine, and tyrosine residues were the most prevalent amino acids at
curcumin binding sites on the protofibril surface. Radial distribution function profiles
(RDF), normalized by the number of atoms in each amino acid, were generated as well, to
understand binding pocket residue distribution during the simulation.44,55 Consistent with
contact number analysis, phenylalanine residues have the highest probability of binding to
curcumin for Complex I-A followed by valine residues (Figure 4.5b). The binding site of
Complex I-B shows a high probability of tyrosine residues binding to curcumin, while
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Complex I-C has more phenylalanine residues in the binding regions, similar to Complex
I-A. For Complex I-D, both
a

I-A

I-B

phenylalanine

and

tyrosine

RDF peaks are smaller, within
I-C

I-D

30 Å. Overall, valine is the
second most prevalent residue

b

II-A

in the curcumin binding sites.

II-B

The hydrophobic character and
high abundance of valine on
II-C

II-D

the fibril surface may explain
its prevalence in curcumin

Figure 4.4. Zoomed in image of bound curcumin
complexes after 100 ns of MD from System 3,
Trajectory I (a) and Trajectory II (b). The leftmost
image in (a) and (b) shows all complexes with
enlarged images for each complex to the right. All
amino acids 5Å from each complex are shown in stick
representation.

binding sites. The non-zero
asymptotic value for the RDFs
of valine at distances greater
than 30 Å can be attributed to

high valine content (6 valines per monomer) across the entire protofibril and the size of the
simulation box. Most of the RDF plots for Trajectory II indicate high prevalence of
phenylalanine and tyrosine, which is in agreement with results obtained from Trajectory I.
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4.3.2 Hydrophobic driving forces for curcumin assembly
We hypothesized that the overall hydrophobic character of curcumin and the
protofibril would contribute to favorable

Number of contacts

a

binding. Trajectories I and II of System 3
showed that many hydrophobic regions of
the protofibril are curcumin binding sites.
This pattern was observed in 100 ns
snapshots

of

the

simulations

150
100
50
0
PHE

b

(not

VAL

TYR

I-A

g(r)

pictured), where curcumin appears to lie
along the contours of the hydrophobic

PHE
VAL
TYR

pockets (orange) on the protofibril sides
and ends.
All

c
bound

curcumin

form
g(r)

complexes of two or more molecules,
indicating that curcumin self-assembly

generated for curcumin dimers to track the
dynamics

of

curcumin-curcumin

complexation for System 3 trajectories

0 ns
10 ns
100 ns

0.6
0.3
0

may be an additional factor contributing to
the binding process. RDF plots were

0.9

-0.3
0

(Å)
5 Distance
10
15

20

Figure 4.5. (a) Number of contact points
within a 5 Å radius of Complex I-A for
PHE, VAL, and TYR residues. (b) Radial
distribution function (RDF) for Complex IA curcumin dimer. (c) RDF of Complex IA curcumin dimer at 0, 10, and 100 ns.

(Figure 4.5b for Complexes I-A). As Complex I-B features a curcumin trimer, we used
only the two curcumin closest to the protofibril to generate the corresponding RDF. At 0
ns, the curcumin-curcumin RDFs are flat, as the curcumin are initially placed greater than
20 Å apart. In each case, after 10 ns, curcumin molecules begin to self-assemble as
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indicated by the appearance of a peak at approximately 5Å for Complex I-A and I-B.
Complexation between the curcumin pairs is maintained throughout the remainder of the
simulation as the RDF peaks show little change at 100 ns. Complex I-C forms more slowly
which could explain the smaller peak seen in the corresponding RDF. Complex I-D begins
to develop at 10 ns reaching a maximum at the end of 100 ns.
To determine whether curcumin complexation occurs in the absence of a
protofibril, a simulation of 12 curcumin molecules was carried out (System 4 in Table 4.1)
at identical starting positions as those in System 3. A number of dimers begin to form at 4
ns (data not shown) followed by

a
0.6

ns leading to a large aggregate at

0.3

g(r)

the appearance of a tetramer at 8

0 ns
45 ns

0

approximately 27 ns. By 45 ns, a

-0.3

large complex containing eight

0

b

were formed (Figure 4.6a). A
that

tracks

the

complexation of two curcumin
molecules (colored purple and

0 ns
20 ns, water
20 ns, methanol

0.9

g(r)

plot

0.6
0.3

simulation shows that curcumin
readily form complexes, without

water

methanol

0
0

5

10

15

20

Distance (Å)

yellow in Figure 4.6a) confirms
dimerization at 45 ns. This

20

Distance (Å)

curcumin molecules and a dimer

RDF

10

Figure 4.6. (a) Images showing the complexation of
curcumin in absence of the fibril. RDF is shown for
the curcumin pair colored in yellow and purple in the
images. (b) RDF and images of curcumin trimer
when placed in methanol (lower right image) as
compared to water (upper right image in b).

a substrate, in aqueous solution.

96

To further examine the role solvent plays on curcumin complexation, the curcumin
trimer from Complex I-B was extracted and placed in water or in methanol; three 20 ns
simulations were run on the extracted complex for each solvent. The RDF profile at 20 ns
overlapped with that of the initial trimer at 0 ns (Figure 4.6b) indicates that the complex
did not dissociate and remained intact. In contrast, when the trimer was solvated in
methanol (System 7), the complex rapidly dissociated during the 20 ns simulation (Figure
4.6b). Results from these simulations show that curcumin assembly is favored in an
aqueous solvent even in the absence of a binding substrate.
4.3.3 Energetics of curcumin-protofibril binding and curcumin complexation
Free energies of curcumin-protofibril binding (∆GBind) were obtained using MMGBSA calculations for Trajectories I and II of System 3. Since curcumin predominantly
bind as complexes on the fibril surface, two approaches were used to calculate ∆GBind to
account for two different pathways. In the first approach, curcumin complexes were
selected as the “ligand” and binding energy between the curcumin complex and the
protofibril (substrate) yielded ΔG1 (Table 4.2), which ranged from -11 to -27 kcal/mol,
indicating moderate to strongly favorable binding between the curcumin complex and
protofibril. In the second approach, the binding energy between the single closest fibril
bound curcumin (ligand) and the protofibril (substrate) was calculated (ΔG2), which ranged
from about -4 to -16 kcal/mol (Table 4.2). These binding energies again demonstrate
favorable curcumin-protofibril surface binding. The effect of complexation on protofibril
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binding can be gleaned from differences between ΔG1 and ΔG2 values. With the exception
of Complex I-D, single curcumin binding was less favorable than curcumin complex
binding. Favorable curcumin complexation, as demonstrated by our simulations (Figure
Table
Curcumin-fibril
BindingEnergies
Energies(kcal/mol)
(kcal/mol)
Table2.4.2
Curcumin-fibriland
andCurcumin-Curcumin
Curcumin-Curcumin Binding
ΔG1

ΔG2

ΔG3

ΔG4

I-A

-22.2 ± 2.2

-4.30 ± 0.9

-15.9 ± 1.8

-12.0 ± 1.0

I-B

-16.0 ± 3.9

-13.4 ± 1.9

ND

-11.6 ± 1.3

I-C

-15.5 ± 2.2

-11.3 ± 2.5

-17.6 ± 2.7

-10.2 ± 1.1

I-D

-11.9 ± 1.9

-14.0 ± 1.4

-11.4 ± 1.1

-11.5 ± 1.1

II-A

-21.0 ± 1.7

-15.7 ± 1.7

-18.1 ± 0.6

-11.5 ± 1.7

II-B

-12.0 ± 2.2

-9.54 ± 1.6

ND

-10.6 ± 1.7

II-C

-18.9 ± 4.0

-12.6 ± 1.7

-12.6 ± 2.0

-11.0 ± 1.6

II-D

-27.6 ± 2.1

-9.95 ± 1.9

-9.1 ± 1.6

-10.8 ± 1.0

curcumin
complexes

4.6), certainly contributed to the observed binding of curcumin complexes to protofibrils.
To quantify the contribution of curcumin-curcumin complexation to curcumin
complex-protofibril binding, curcumin dimers from each complex in Table 4.2 were
extracted and the free energy of curcumin dimerization (ΔG4) was calculated and an
average value of -11.2 ± 1.3 kcal/mol was obtained (Table 4.2). Structures of curcumin
dimers show that most of them are aligned with the phenyl rings stacked directly on top of
one another likely due to π-π interactions.
To assess whether curcumin complexation and curcumin-protofibril binding are
synergistic or additive, we calculated the free energy of binding between the fibril with a
single bound curcumin (substrate) and an additional curcumin (ligand) for all curcumin
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dimers (ΔG3) (Table 4.2). ΔG3 thus represent the free energy of binding for the addition of
a curcumin to an already bound curcumin on the protofibril surface. ΔG3 values are all
negative,

indicating

energetically

favorable

a

ΔG4

addition of curcumin to an
already bound curcumin on

ΔG1
ΔGBind

the protofibril surface.
Dynamics
curcumin
further

of

binding

was

investigated

by

examining the snapshots of
Trajectories I and II of
System 3. In two cases,
Complexes I-C and II-C,
single

curcumin

binding

occurs first, following by
curcumin addition to form
the bound curcumin dimers.

ΔG2

ΔG3

b
Complex

ΔG1 + ΔG4

ΔG2 + ΔG3

I-A

-34 ± 2.4

-20 ± 2.0

I-C

-25 ± 2.5

-28 ± 3.7

I-D

-23 ± 2.2

-25 ± 1.8

II-A

-32 ± 2.4

-34 ± 1.8

II-C

-30 ± 4.3

-26 ± 2.6

Figure 4.7. Possible pathways for the formation of a full
curcumin dimer-protofibril complex (a). Corresponding
summation of ΔG values (kcal/mol) for each process are
shown for the five complexes involving a curcumin
dimer.

In other cases, Complexes I-A and II-A, curcumin dimerization occurred prior to binding
to the protofibril. Both pathways lead to stable binding of curcumin complexes to the
protofibril and yielded comparable values of ΔG1 and ΔG3. The thermodynamic cycle for
the two pathways is shown in Figure 4.7a, which shows ΔG values involved with each step
leading to curcumin complex-protofibril binding. The ΔG values of the two pathways, ΔG1
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+ ΔG4 and ΔG2 + ΔG3 for the five curcumin dimer complexes are shown in Figure 4.7b.
Although they are not equivalent, the magnitudes of these ΔG sums are comparable,
indicating that both pathways are similarly thermodynamically favored and that curcuminprotofibril binding and curcumin complexation are likely additive, not synergistic, events.
One additional detail to note is the difference in ΔG sums for Complex I-A (-34 vs. -20
kcal/mol). This particular complex is bound at an angle while the corresponding trajectory
with the outermost curcumin removed resulted in a single curcumin lying flat along the
protofibril surface. In other words, the ΔG2 for this complex involves a curcumin molecule
that makes additional contact with the protofibril which could contribute to the difference
of 14 kcal/mol between added ΔG values.
The two curcumin in Complexes I-A and II-A self-assemble almost immediately
after minimization and equilibration. The dimers then bind to a phenylalanine-rich site
along the β-sheet backbone. From Table 4.2, it is seen that the binding energy of the dimer
in Complex I-A is much more favorable (-22 kcal/mol) than that of the individual (closest)
curcumin (-4 kcal/mol). Upon closer inspection of the binding positions of these
curcumins, it appears that one aromatic ring group of each curcumin is in close contact
with a phenylalanine residue. When one curcumin is removed, part of the favorable
interactions with the protofibril is gone which could explain the weaker binding of the
single curcumin to the surface. All other complexes (except II-D) have comparable ΔG1
and ΔG2 values, but ΔG1 is consistently more negative. Curcumin complexation thus
contributes overall favorably to its binding to the protofibril surface, although the binding
process could be quite dynamic, as evidenced by detailed tracking of complex formation
in our simulations.
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In addition to primarily
binding as complexes, curcumin

Trajectory I

a I-E

I-G

I-F

also binds to the protofibril as
single molecules. Three curcumins
Trajectory II

became bound to the ends of the

II-E

II-F

protofibril in Trajectory 1 (Figure
4.8a), with one inserted into the
protofibril end (Complex I-F). In

b

Trajectory II, one curcumin bound
to an end of the protofibril
(Complex II-E) and one to the side
(Complex

II-F).

Negative

Single curcumin
complexes

ΔG fibril of single
curcumin to fibril

I-E
I-F
I-G
II-E
II-F

-17.30 ± 2.6
-31.49 ± 1.5
-29.16 ± 1.8
-9.78 ± 1.2
-6.28 ± 1.1

ΔG

values of these binding events
(Figure 4.8b) indicate favorable

Figure 4.8. Images (a) and estimated binding
energies (b) of singly bound curcumin at 100
ns in two System 3 trajectories.

binding especially for complexes I-F and I-G which feature a high number of contacts with
hydrophobic residues. When curcumin inserts into to the protofibril ends, such as Complex
I-F, ΔG is greater than any of the complexes featuring bound curcumin complexes.
This all-atom explicit solvent MD simulation study shows that curcumin exhibits a
pattern of non-specific, but distinct binding sites on an Ab40 protofibril. Curcumin
favorably binds either as complexes (dimers, trimers, and tetramers) on the fibril surface
or as single molecules at fibril ends. The hydrophobic amino acid rich areas of the
protofibril, especially rows of phenylalanine, valine, and tyrosine promote curcumin
association. Curcumin self-assembly is energetically favored in an aqueous environment
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and curcumin complexation contributes to its protofibril surface binding by about ~10
kcal/mol. Further analysis revealed that curcumin complex-fibril binding proceeds by
either the formation of a curcumin complex followed by binding of the complex to the
protofibril or by the binding of a single curcumin to the protofibril followed by subsequent
binding of other curcumin molecules at that site. Both pathways were observed in MD
simulation trajectories and yielded comparable DG values (-28 kcal/mol for preformed
complexes and -26 kcal/mol for stepwise assembled complexes). Our simulation
trajectories indicate that both pathways, binding of curcumin complexes to the fibril and
the stepwise assembly of curcumin on the fibril surface, are thermodynamically and
kinetically competitive.
Curcumin binding to the protofibril did not cause noticeable changes to the
protofibril structure during the 100 ns simulation trajectories. This result is similar to that
from the all-atom MD simulation study of Lemkul and coworkers that showed that the
binding of the flavonoid morin to the outer perimeter of an Aβ42 pentamer did not alter
pentamer stability.32 Binding energies calculated from previous docking and short time
(20 ns) MD simulations of curcumin and two nonsteroidal anti-inflammatory drugs
(ibuprofen and naproxen) to monomeric Aβ40 peptides and small Aβ40 fibrils43 have
shown that curcumin exhibited the strongest binding (-13 kcal/mol) to the fibrils. These
binding energies are comparable to the ΔG values obtained from our study that ranged from
-10 to -16 kcal/mol for singly bound curcumin. Our simulations have also identified
additional binding modalities of curcumin. These result in curcumin complexation on the
protofibril surface that can further contribute to favorable binding. DG values ranging from
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-11 to -27 kcal/mol were obtained for the binding of curcumin complexes to the protofibril
surface.
As observed in our simulations, hydrophobic residues play a key role in curcumin
binding including aromatic residues such as phenylalanine.32,43 This highlights the fact that
the alignment of multiple hydrophobic residues along the fibril surface creates a scaffold
that promotes the binding of amphiphilic small molecules such as curcumin. Moreover, the
hydrophobic backbone of the curcumin molecules also favors their complexation to form
aggregates by stacking on the protofibril surface.
Aggregation of curcumin has also been observed in lower resolution coarse-grained
(CG) simulations on Aβ protofilaments with curcumin using discontinuous MD.44 The
general binding trends reported for curcumin in this study are similar to that observed by
our all-atom trajectories. In particular hydrophobic residues like phenylalanine and
tyrosine dominate the number of contacts with curcumin in the binding pockets. The CG
results are consistent with our findings that curcumin does not cause destabilization of the
protofibrils. In comparison to our study, curcumin self-association occurs to a lesser extent
in the CG simulations. In particular, only curcumin dimer formation was observed in
contrast to dimers, trimers and even tetramers seen in our all-atom simulations. This could
be due to the differences in force field parametrization and the presence of explicit water
molecules.
Other all-atom simulation studies have also explored the binding of small sensor
molecules to Aβ protofibrils.37,41 The binding energies of ThT to a smaller 8 peptide Aβ
protofibril (with 7 amino acids per peptide) determined using MM-GBSA were around -4
kcal/mol.37 This is significantly less favorable than most of the values we obtained for
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single curcumin binding. This is likely due to the positive charge of ThT, since in this same
study the binding energies of an uncharged ThT analog, BTA-1, were found to be around
-16 kcal/mol. The neutral molecule displayed enhanced binding compared to ThT and the
binding energies are quite similar to the values we obtained for single curcumin binding to
the protofibril. Like curcumin, ThT and BTA-1 feature multiple hydrophobic rings which
would promote favorable binding to the β-sheet rich regions enriched with phenylalanine
residues. In our simulations, curcumin exhibits similar behavior to BTA-1, where a
preponderance of hydrophobic residues (valine, phenylalanine, and tyrosine) are found at
the binding sites. As in the case of our curcumin studies, dimer formation is also observed
in the BTA-1 simulations, via the stepwise addition of one molecule to an already bound
BTA-1. Both curcumin and BTA-1 bind to Aβ on timescales accessible to MD simulations
when placed diffusely around a protofibril.
4.4 CONCLUSIONS AND FUTURE DIRECTIONS
Our study shows that curcumin exhibits a pattern of non-specific, but distinct
binding sites on an Ab40 protofibril. Curcumin favorably binds either as complexes on the
protofibril surface or as single molecules at fibril ends. Curcumin self-assembly enhances
binding to Aβ protofibrils. As shown in our curcumin-only control simulations, the
aqueous environment is a major factor driving curcumin complexation on the protofibril
surface. The binding energies of curcumin complexes are much higher than the binding of
single curcumin molecules alone to the protofibril surface. Binding of curcumin to
numerous hydrophobic locations on the protofibril surface could act to block toxic sites on
the Ab oligomer surface. These toxic sites interact with and disrupt the lipid membrane
and have been hypothesized as a pathway for exerting neurotoxicity.56–58 Simulations from
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this study also show that in general, curcumin binds to the hydrophobic sites on the
protofibril by 20 ns and remains bound during the course of at least 100 ns. Binding of
curcumin to the fibril growth ends (in some cases resulting in deep insertion of curcumin
into the protofibril) may disrupt or interfere with further peptide assembly on the ends of
Aβ causing “off-pathway” worm-like fibril morphology observed in previous experimental
work.30 A molecular-level understanding of the driving forces and dynamics of curcumin
binding to Ab protofibril carried out in this study provide insight into how curcumin binds
to protofibrils, and how curcumin self-association alters this binding affinity.
We hypothesize the intercalation of curcumin during the growth of Ab fibrils in
this manner is one way the experimentally observed “worm-like” fibrils may form. Future
simulations using steered molecular dynamics and analysis of the molecular level growth
mechanism in presence and absence of curcumin will allow us to elucidate additional
details surrounding this behavior. This information can ultimately lead to the design of
small molecules that could ameliorate the toxicity and induce off-pathway fibril formation
of Ab40.
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CHAPTER 5: Microsecond Timescale Simulations of Amyloid-β
Hairpins with Zwitterionic and Anionic Lipid Membranes.
5.1 INTRODUCTION
One of the primary modes of neuronal destruction in AD is disruption of the
neuronal membrane by

DMPC

Aβ aggregates, resulting
in water leakage and
DMPG

alteration of ion transport
regulation1.

and
Assembly
beta

into

of

amyloid
insoluble

aggregates is kinetically
unfavorable due to the

GYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV Aβ monomer
sequence

Figure 5.1. Structures of lipids and sequence of Aβ hairpin
(N terminus to C terminus is left to right) studied in this
work. Residues one letter codes are colored either orange
(non-polar), green (polar, neutral), blue (cationic), or red
(anionic).

energy barrier to the initial nucleation phase. However, there is evidence that interfaces,
such as membranes, reduce the activation energy and induce protein aggregation2,3.
It has been shown in prior experimental work4,5 that anionic phosphorylglycerol
lipids promote or template the aggregation of misfolded Aβ peptides. However, in the
presence of zwitterionic phosphorylcholine lipids, this behavior is not observed5. These
experimental findings have shed light on Aβ aggregation in lipid monolayer and bilayer
systems, but additional details at the molecular scale remain to be elucidated. In addition,
low molecular weight AB oligomers are known to be the primary neurotoxic species in
AD6,7. Further understanding of the interactions between these smaller Aβ morphologies
and lipid bilayers is therefore crucial.
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Molecular dynamics (MD) simulations have been used at varying time scales (from
ns to μs for united-atom based systems8) to investigate amyloid-β-lipid interactions9 and
implications of oligomerization at the water-membrane interface10–12. Monomeric,
oligomeric, and protofibrillar Aβ preinserted into various membrane systems including 1palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) have also been investigated,
resulting in membrane thinning and water pore formation13–15. While enhanced sampling
methods such as replica exchange MD have been used to explore all-atom, explicit solvent
Aβ-membrane systems8, longer timescale (μs) level computational studies can lend
valuable insight into Aβ aggregation in the presence of model membranes.
The goal of this work is to implement specialized all-atom molecular dynamics at
the microsecond time scale to explore Aβ interactions with model lipid bilayers and
determine the extent of peptide aggregation at the membrane-water interface. Our
simulations have allowed us to begin to characterize these molecular level interactions and
analyze the aggregation process of separate Aβ in the presence of model lipid bilayers with
varying amounts of 1,2-dimyristoyl-sn-glycero-3-phosphorylglycerol (DMPG) and 1,2dimyristoyl-sn-glycero-3-phosphocholine (DMPC) lipids. The aggregation of Aβ proteins
at the membrane surface is a key component of understanding the mechanism of bilayer
disruption prevalent in advancement of AD.
5.2 COMPUTATIONAL METHODS
5.2.1 Simulation Details
Peptides used in the simulations were obtained from a short Aβ40 protofibril (PDB
2LMN16) which contains residues 9-40, placed on one side of the bilayer. Five of these
hairpin peptides were placed approximately 5 Å apart (40 Å minimum center of mass
distance between them). Systems were prepared using the online CHARMM-GUI
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membrane builder17. Three bilayers each containing 226 lipids were constructed with either
pure zwitterionic DMPC, pure anionic DMPG (anionic) lipids, or a 1:1 DMPC:DMPG
mixture. Both Aβ and lipid molecular structures are shown in Fig. 5.1. All lipids and
peptides were parameterized using the CHARMM36 force field. Water molecules were
represented explicitly (TIP3P model) and an NaCl counterion concentration of 0.15 M was
used. The temperature was set to 303.15 K (30° C). The short-range cutoff for nonbonded
interactions was 12 Å and the PME model was used to describe long-range electrostatics.
Initial equilibration was performed with the NAMD software package18 on the San Diego
Supercomputing Center (SDSC) supercomputer, Comet, via the Extreme Science and
Engineering Discovery Environment (XSEDE)19. Unless noted, all simulation parameters
were kept at default values. NPT (constant number of particles, pressure, and temperature)
production simulations were implemented using specialized MD software available on the
Anton 2 machine at the Pittsburgh Supercomputer Center (PSC)20, to reach μs timescales.
Three trajectories per system were obtained using this approach. Analysis of contact points,
secondary structure, and membrane thickness was carried out using the VMD software
package21 and visualization was performed using UCSF Chimera22.
5.3 RESULTS AND DISCUSSION
5.3.1 Aβ -lipid association is dependent on membrane composition
Simulations were carried out on three lipid systems including pure zwitterionic
DMPC, pure anionic DMPG, and equal parts DMPC to DMPG. The focal point of these
simulations was to position five Aβ peptides in a β-hairpin conformation at the membrane
surface to determine if the lipids promote their assembly and insertion. Top-down and side
views of the trajectories after equilibration (0 μs) and at the 1 μs timepoint are shown in
Fig. 5.2. Fig. 5.3 A-C shows representative snapshots from the resulting trajectories at 1
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μs. Visualization indicates little to no insertion of the Aβ peptides regardless of lipid type.
However, there is evidence of peptide-lipid interactions of different extents depending on
the amount of anionic DMPG present. The pure DMPC system shows little to no contact
between Aβ and the lipid-water interface. It is clear that as DMPG content increases, more
of the peptides remain near the lipid surface. Interesting to note is the separation of Aβ into
two oligomers in the presence of pure DMPG, which is indicative of a potential kinetic
competition between peptide-peptide and peptide-lipid interactions. That is, our
simulations show that the Aβ peptides aggregate away from the membrane in the case of
pure DMPC, but as DMPG increases a portion of these peptides remain at the lipid-water
interface.
Contact

point

analysis was performed

DMPC

between each of the five
peptides

and

the

respective lipids present

DMPG/DMPC

in each system. Fig. 5.3
D-F shows representative
contact “heat” maps for

DMPG

0 μs

each system indicating
representative

Aβ

peptides closest to the
lipid molecules within 4
Å along the simulation

1 μs

Figure 5.2. Snapshots of each system at the beginning (0
ns) and end (1 μs) of the simulations. Aβ peptides
categorized by hydropathic character with red indicating
hydrophobic and blue indicating hydrophilic residues.

119

time course. In the case of pure DMPC, there are few contacts (white squares) made. When
contacts are made between Aβ and DMPC, they vanish quickly as shown in Fig. 5.3D.
Increased association occurs between Aβ and the mixed DMPC/DMPG bilayer with
sequential amino acids including two valine residues maintaining contact for ~0.5 μs (Fig.
5.3E). Pure DMPG resulted in the most Aβ-membrane contact points with a higher number
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GLU
VAL
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LYS
LEU
VAL
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PHE
ALA
GLU
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VAL
GLY
SER
ASN
LYS
GLY
ALA
ILE
ILE
GLY
LEU
MET
VAL
GLY
GLY
VAL
VAL

C.

B.

D.

E.

F.
0

250

0

0.5
time (μs)

DMPC + Aβ

1

0

0.5

1

DMPC/DMPG + Aβ

0

0.5

1

DMPG + Aβ

Figure 5.3. Snapshots of Aβ peptides and membrane surfaces at the 1 μs time point.
Lipids are shown in stick representation with head groups in orange and tails in tan (AC). Peptides are colored to show hydrophilic (green, blue, red) and hydrophobic
(orange) regions. Peptide-lipid contacts within 4 Å over time ranging from 0 (black) to
250 (white) contacts (D-F) along a 1 μs simulation trajectory. The legend (left) indicates
residues categorized as either non-polar (orange), polar neutral (green), anionic (red),
or cationic (blue).

of residues (up to 6 consecutive amino acids for one case) consistently within 4 Å (Fig.
5.2E) for over 0.5 μs. It is clear as the amount of DMPG lipids increase, more Aβ remain
nearby as the number of contact points rises as high as 250 and persist for longer periods
of simulation time. Hydrophobic interactions appear to influence the peptide-lipid

120

association as the majority of amino acids are in the range of 29 to 40 and include glycine,
isoleucine, and other non-polar residues (Fig. 5.1)
5.3.2 Aβ oligomerization does not impact membrane structure at 1 μs
Water leakage (travel of water molecules across the membrane) did not occur in
any of our simulations based on visualization. This was confirmed by plotting membrane
thickness profiles at 1 μs of each system (not shown). This is largely due to the tendency
of the peptides to assemble away from the bilayer surface and suggests that the peptidepeptide interactions are kinetically favored over those between peptide and lipid bilayer at
Table 5.1. Area per lipid (APL) and membrane thicknesses

System
DMPC
DMPC + Aβ
1:1 DMPC/DMPG
1:1 DMPC/DMPG + Aβ
DMPG
DMPG + Aβ

2

APL (Å ) Thickness (Å)
61.5 +/- 0.8 35.7 +/- 0.4
61.6 +/- 0.8 35.7 +/- 0.4
60.0 +/- 1.0 35.8 +/- 0.3
58.6 +/- 1.2 36.2 +/- 0.4
59.2 +/- 1.3 36.3 +/- 0.4
60.4 +/- 1.1 35.7 +/- 0.5

the microsecond timescale. We also performed control simulations of each of the lipid
bilayer compositions to 1 μs and analyzed the membrane thicknesses. The behavior was
comparable to the systems with Aβ peptides present with occasional fluctuations in
thickness of approximately 1 nm. Changes in bilayer thickness by a similar amount have
been reported in nanosecond MD studies11,23. On average, area per lipid (APL) and bilayer
thickness did not change significantly upon addition of Aβ regardless of membrane type
(Table 5.1). Literature values for experimental APL and membrane thickness of pure
DMPC at 30° C have been reported as 59.9 Å2 and 36.7 Å, respectively24. This agrees with
the average values from our computational study both in presence and absence of Aβ and
again confirms no membrane thinning or leakage of water molecules. DMPG membrane
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properties fluctuate more; however, the beginning and ending APL and thicknesses
remained at approximately 59 Å2 and 36 Å, respectively.
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Figure 5.4. Representative contact maps between two peptides. Images of one
interacting peptide pair are shown in green and purple (top) with other nearby
peptides shown in cyan spheres at 1 μs with non-polar, polar neutral, cationic, and
anionic residues shown in orange, green, blue and red, respectively.
5.3.3 Peptide-peptide interactions are altered by membrane composition
Peptide-peptide interactions appeared frequently in all trajectories with formation
of dimers and pentamers. Contact point profiles between pairs of Aβ peptides show clear
patterns in aggregation with the overall number of contacts between peptide pairs reaching
100-200 within a 4 Å distance. We also investigated the secondary structure of each of the
peptides. Fig. 5.5 shows the amount of each type of secondary structure (%) for all Aβ
peptides.
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Over half of the amino acid residues in each system were unstructured (coil) at 1 μs. The
next prevalent secondary structure observed was turn which indicates a change in amino
acid direction. This feature is common to beta sheet conformations in proteins25. Some
changes did occur in each of the Aβ peptides including appearance of helical conformations
for one peptide in the pure DMPC system (5% of the amino acids at 1 μs adopted helical
structure). There were also differences in amount of β-sheet content (extended or E in Fig.

70%

Coil
Turn
Beta-sheet
Isolated bridge
Helix

60%
50%
40%
30%
20%
10%
0%
Aβ + DMPC

Aβ + DMPC/DMPG

Aβ + DMPG

Figure 5.5. Secondary structure content summed over all peptides in each
system.
5.5) which increased to 18% and 13% for the DMPC/DMPG and pure DMPG systems,
respectively, as compared to 3% B-sheet amino acids in the pure DMPC system. This likely
is due to the different lipid compositions, as peptides with more lipid contacts (which
increase with higher DMPG concentration) contain higher amounts of β-sheet residues. We
performed secondary structure analysis for the entire simulation (data not shown) and little
change occurred especially with respect to beta sheet and coil conformations.
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5.4 CONCLUSIONS AND FUTURE DIRECTIONS
In this study we investigated Aβ aggregation on the microsecond timescale with
model membranes consisting of zwitterionic and anionic lipids. Our results agree well with
previous experimental evidence that Aβ interacts with anionic lipids including DMPG
compared to membranes with zwitterionic

Pure DMPG

DMPC5. While we did not observe insertion of
the peptides into the bilayer, we did find a clear
increase in peptide-lipid interaction in the systems
containing higher concentrations of DMPG.
Initial trajectory visualization indicates the

Pure DMPC

cationic residues on the peptides interact with the
anionic DMPG head groups (Fig. 5.6). We also
observed little change in membrane thicknesses
and area per lipid regardless of membrane
composition.

Peptide-peptide

interactions

showed prevalent self-assembly in the pure
DMPC

system

with

all

five

monomers

Figure 5.6. Snapshots of the pure
DMPG and DMPC systems at 1
μs. Cationic groups are shown in
blue for the peptides and cyan for
the lipid head groups. Anionic
lipid head groups are colored
orange.

aggregating. As DMPG increased, the peptides assembled in smaller aggregates with some
remaining close to the membrane.
It is important to note that aggregation and insertion are complex, dynamic
processes that can take up to milliseconds. Simulations with a preformed and preinserted
Aβ oligomer are needed in the future to compare to our findings in this work. In addition,
future studies will be performed with more heterogeneous membranes to mimic a more
realistic lipid composition. This study will also provide a starting point for simulations
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using steered molecular dynamics (SMD) in order to investigate the energetic details
governing Aβ oligomer-membrane interactions. In these simulations we will apply
potential of mean force (PMF) calculations while steering a membrane-bound Aβ oligomer
away and measuring the resulting energy change. Furthermore, we will explore the impact
on the Aβ-membrane association in an environment modeling cellular crowding via
addition of osmolytes.
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CHAPTER 6: Design of Adaptive Devices.
6.1 INTRODUCTION
In the U.S., 1 in 4 individuals have a disability with many needing wheelchair
assistance1. There are multiple illnesses, long-term and short-term, in addition to aging
causing individuals to have decreased mobility and motor function. Alzheimer’s disease
and dementia patients are among these groups. Another disease impacting mobility is
muscular dystrophy (MDy), with the most common forms affecting 1 in every 5,600 to
7,700 males ages 5 to 242. MDy results in progressive loss of muscle strength and
wheelchair use often by age 12 according to the Muscular Dystrophy Association (MDA)3.
Those with progressive diseases such as AD and MDy often require aid from a caregiver,
specialized tools, or both, to carry out activities of daily living (ADL)4.
Other challenges to mobility can be shorter in duration, such as recovery from
surgery and short-term strains and sprains, but still often require assistive devices to
complete certain activities. Limitations in mobility present a substantial barrier to ADL
such as bathing, drinking water, charging electronic devices, and storage/transport of books
or laptops. Current technology suffers from a lack of adaptability and frequently provides
only partial or temporary solutions for the specific needs. Moreover, limited modularity is
persistent, particularly in products designed for personal hygiene which often have
restricted height ranges (typically less than 20 inches).
This issue impacts motorized wheelchair users frequently as the height of the chair
with the seat and base included start at 23 inches. This height difference seems small;
however, many limited-mobility individuals use lateral transfers to slide from wheelchair
to shower seat making non-flush surfaces problematic and difficult even with the aid of a
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caregiver. An additional complication is the fact that insurance providers frequently neglect
items for personal hygiene as they deem bathing a luxury activity5. However, the Center
for Disease Control (CDC) reports a multitude of health issues caused by poor personal
hygiene including scabies, lice, and ringworm6. Failure to effectively and routinely clean
may result in more severe consequences such as open wounds or sores that can become
infected CDC.
Bathing or showering successfully is one specific example of a plethora of
challenges centered around adaptive mobility and ADL needs. Many of the problems
demonstrate a disconnect between the developers and intended users of the assistive tools.
In this work we discuss four adaptive design projects geared towards providing user, or
“need-knower”, informed devices that are modular, safe, affordable and aesthetically
pleasing. The first device, Shower Chaise, provides a solution for overcoming personal
hygiene barriers described earlier, with interchangeable modules specific to the needknower. Another device we are developing (for wheelchair users initially) is designed to
help with storage and transport of accessories including wheelchair charging units. This
technology is called the Solar Integrated Design for Electronics Kept In Customized Kit
(SIDEKICK) as future additions will be incorporated to provide solar charging capabilities.
A related item, the cupholder, is also under development to ensure proper hydration by
wheelchair users via a conveniently positioned lock-line hose with a specialized
mouthpiece for independent drinking. We have also begun fabrication of a tool for students
and laptop users with disabilities called the Personal Ergonomic Removable Custom
Hybrid Desk or PERCH-D that will provide an adjustable surface to wheelchair users for
both writing and typing.
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6.2 MATERIALS AND
METHODS
6.2.1 Surveys
Google Forms were used to create
a survey for Shower Chaise to
gain insight into the needs of
wheelchair

users

and

their

caregivers. A snapshot of the
survey is given in Fig. 6.1 and will
serve as a starting point for
creating surveys for the other
three

devices

(available

at

Figure 6.1 Sample questions from survey for
Shower Chaise to garner initial feedback from
need-knowers or caregivers familiar with
mobility limitations.

https://docs.google.com/forms/d/e/1FAIpQLSd4Uy2SeO5sb_oCZVPo0d5mzDQ_F4PQ
KeufcmoMwP9fS7A9Bg/viewform). IRB approval will be obtained in order to collect and
disseminate our findings.
6.2.2 I-Corps
Three of the devices (Shower Chaise, SIDEKICK, and PERCH-D) were accepted by the
NSF funded STC.UNM Innovation Corps (I-Corps) site program. I-Corps is focused on
lean entrepreneurship and potential customer discovery for development of innovative
products and devices. Program requirements included conducting interviews with potential
users, manufacturers, and medical professionals in addition to design analysis and
development of potential marketing plans. A total of 25 individuals were interviewed for
each device including need-knowers/potential users, people involved with manufacturing
specialists, and professional experts such as physical and occupational therapists. Tye
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Martin was the entrepreneurial lead on Shower Chaise and SIDEKICK while Laura
McKenney carried out all I-CORPS activities for the PERCH-D. Final presentations were
given in the Fall of 2017, Spring of 2018, and Fall 2018 to a panel including New Mexico
startup company CEOs. Each project was evaluated for potential success at the national ICorps team program (with a travel award of $50,000). All three of the projects were
recommended by the panel for continuation.
6.2.3 3D Printing
3D models were printed using the MakerBot computer aided drafting (CAD) software7.
Printing of prototype components was carried out using MakerBot Replicator 2X printer8
with Acrylonitrile butadiene styrene (ABS) filament located at the UNM Center for
Biomedical Engineering.
6.2.4 Rapid Prototyping
Rapid prototyping was carried out in phases for the PERCH-D and cupholder projects
beginning with need-knower interviews5 and iterative design following the IDEO
framework9. Analogous products were explored (i.e. a composer stand for a laptop tray)
and provided initial ideas for construction of the early prototypes. Testing by design teams
for devices with prototypes (PERCH-D and Cupholder) was carried out in multiple stages
and has resulted in 5 iterations for PERCH-D and 2 iterations for Cupholder to date.
6.3 RESULTS AND DISCUSSION
We targeted five areas for developing and fabricating each adaptive device, including
surveys, customer discovery through the NSF-funded Innovation Corps Program, 3D
printed models, rapid prototyping, and evaluation of user experience (UX).
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Table 6.1 Completed and planned fabrication phases of each device.
I-CORPS

Surveys

Renderings

3D print

Shower Chaise

✔

✔

✔

✔

✔

SIDEKICK

✔

✔

✔

✔

✔

PERCH-D

✔

✔

Cupholder

✔

✔

Prototype

User Experience

✔

✔

✔

✔

IP

6.3.1 Shower Chaise
Current options available to enable maintenance of hygiene needs in populations
with mobility limitations are lacking. Many of these products are equipped with minimal
features and fail to offer affordable customization. As a solution, our group is designing an
adaptive base design shower chair with modular components to be incorporated
based on individual need/situation would substantially improve the bathing
experience provided by nursing homes, hospitals, and in-home care givers.

Softer arm
pads

Stabilizing
suction
cups

Removable
foot/leg rest

Figure 6.2. Rendered graphic (left) and image of initial LEGO ® -based model of
Shower Chaise along with inventors Laura McKenney and Tye Martin (right).
The Shower Chaise is aimed at providing a highly adaptable, modular tool for
overcoming limitations faced by people with reduced mobility or range of motion due to
short and long-term disabilities. The device incorporates features from both patio and office
chairs to circumvent a number of these issues. Highlights of the Shower Chaise include an
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adjustable recliner to allow users to wash and rinse their hair, without getting the upper and
lower body wet, and adjustable armrests to aid in arm support and comfort. Optional utility
baskets or “holsters” for shampoo, soap, and additional personal hygiene items will also be
provided.
Table 6.2. Summary of Shower Chaise features
Height

Adjustable chair heights from 20” to 30” to accommodate many heights
of users, making transfer from wheelchairs safer

Stability

Stability aided by rubber grips on the base of the legs

Water
drainage

Water drainage through pores or slits in the seat and back rest, which will
help the users clean off remaining soap, and prevent buildup of bacteria
when the chair is not in use

Moveable
seat

Sliding seat option to aid in the transfer process from wheelchairs

Foot rest

Optional foot rest component to elevate feet and legs for patients with
long-term mobility issues, or short-term users who need support due to
abdominal surgery

Aesthetics

Colorful and sleek design, rather than utilitarian tan, gray, or other drab
design

This product will feature four major accessory packages including (i) Recovery, (ii)
Adaptive, (iii) Comfort, (iv) Deluxe. The base model, named Recovery (concept art shown
in Figure 6.2), will feature an aesthetically-pleasing cherry and charcoal color pattern with
drop down arm rests and adjustable back and foot supports. This model is aimed at users
who have a short-term need (e.g., during recovery after major surgery) for a support system
that allows them to clean their hair and extremities while supporting the body. It may also
be appealing to people who do not have a disability, but who suffer from conditions such
as fatigue or vertigo that make standing in the shower a concern due to disorientation,
dizziness, and potential fall hazards.
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The various accessory packages (Adaptive, Comfort, and Deluxe) provide
progressively more adaptive interventions. For example, the Adaptive is aimed at users
with a long-term need, such as individuals who are missing a leg, have had a stroke or other
long-term health concern. This package includes holsters for the long-term user’s shower
needs such as shampoo, conditioner, washcloth, extender arm to reach extremities, as well
as an optional extendable hose and trigger nozzle in lieu of the shower head (similar to the
pull-out/pull-down design of kitchen faucets). The Comfort design will provide additional
support structures such as silicone- based “pillows” that will provide support and softer
edges to the user who may need more assistance in the shower and may spend longer in
the shower as a result. The Deluxe design is aimed toward users with extremely limited
mobility and provides support such as a transfer mechanism outside the shower or tub to
the chair. Each of the four additional modules will be color-coded to provide rapid selection
options for users or medical equipment providers, according to the user’s needs. This
device has a provisional patent in place with STC.UNM (“Shower Chaise,” with Martin,
T.D.; Nguyen, P.A.H.; McKenney, L.; Canavan, H.E.; invention disclosure submitted by
STC, November, 2017. Application #62/584,275).
6.3.2 SIDEKICK
Current product drawbacks such as lack of motion, limited attachment points, and
inadaptability contribute to the increasing need of more customizable options for
independence of wheelchair users. While there are a range of separate accessories, such as
the Fleximug10 and SolPro Clamp-on Umbrella11, there is not an effective modular package
with customization to increase independence. Moreover, wheelchair designs vary in
complexity and may not be suited for simple attachment mechanisms. In this work, our
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group is designing an accessory package for wheelchairs with cupholders, rearview
mirrors, and other tools with modularity will be incorporated based on individual
need/situation.
The SIDEKICK will provide all of the necessities that wheelchair users need and
want while they are on the go. The modular design of the sidekick allows the user to decide
the type and number of assistive devices they desire, making it customizable to each user’s

Umbrella
Cup
holder

Rearview
mirror

A

B

Adjustable
arms

Hard
clam
shell

Figure 6.3 Preliminary rendering of SIDEKICK concept art (A). Three
accessories (a cupholder, mirror, and umbrella) are shown and would be
moveable to adapt to the user. Initial 3D print of SIDEKICK clamshell and
adjustable arms.
taste and mobility level. Similar to the side mirrors sold on automobiles and for bicycle
helmets, a mirror will allow the user to visualize the space behind and around the chair to
avoid obstacles, accurately position the chair, and view the other modular items in the
SIDEKICK. By mounting a solar battery to the SIDEKICK, the user will be able to provide
both a mobile charging station for their mobile phone or other devices, as well as their
motorized wheelchair. As the average battery life of a wheelchair is approximately 8 hours
per day, this extends the time that the chair can be in use, and the user can be active.
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Currently, most wheelchair users hang laptop bags or purses from existing
attachment points on the back of their chairs. Although convenient, these attachments are
not designed for this purpose, as they are usually levering to adjust headrests and other
functions. This leads to an unstable storage system where the expensive devices are
swinging around and unprotected. In addition, due to the limited visibility most users
experience with respect to the back of their chair, users will be unaware of people trying to
steal the bag containing their valuables. A hard clamshell case will be an optional module
to store laptops and notebooks, as well as other valuables such as wallets and glasses. The
case will be made of a hard plastic such as ultra-high-molecular-weight polyethylene
(UHMWPE) to provide a rigid case that is capable of withstanding an impact if the user
accidentally backs up into something.
Each of the modules will be created from hard plastics to make them lightweight,
yet sturdy, and (in the case of the cup holder and straw) dishwasher safe. The modules will
be mounted to a rack system via “clickable” easily-detached clips. The mounting rack will
be made from metal to provide the highest durability and strength to the design. In this
way, the actual placement of the modules can easily be adjusted by users and caretakers
such that the SIDEKICK suits the abilities and mobilities of the user, rather than forcing
the users to adhere to a rigid design.
In keeping with the theme of personalization, the materials used to create the
modules described above will come in a variety of colors and patterns to suit the taste of
the individual user. The use of UHMWPE will allow the users to personalize their
SIDEKICK’s design and will be at a suitably low price point to allow for the purchase of
backup modules. This device also has a provisional patent with STC.UNM (“SIDEKICK:
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An Adaptable, Modular System and Apparatus for Personal Wheelchair Accessories,” with
Martin, T.D.; Nguyen, P.A.H.; Matheson, B.; Cuylear, D.; Ista, L.K.; Canavan, H.E.;
invention disclosure submitted by STC, December 4, 2017. Application #62/657,709).
6.3.3 PERCH-D
Limited mobility also presents obstacles in education, both at the K-12 and
university levels, amplified by the need for technology such as laptops and tablets. Storage,
transportation, and usage of these classroom tools can be cumbersome without assistance
from accessibility resource centers (ARCs) or other aid from teachers and fellow students.

Music stand holder

PERCH-D in use

Raised edge

Tilt modifier

Height
adjustment

Figure 6.4 Schematic showing analogous inspiration of composer stand
(left) and Mark IV prototype in use (right).
Typing comfort and efficiency are also critical needs as course curriculum becomes more
technology dependent. Once a computer is removed from a typical backpack the
positioning and stability of the device during usage is problematic for those with more
restricted range of motion. Horizontal based desks can present unique challenges due to
the wide variation in desk height and space for parking a wheelchair. Solutions for adaptive
computer use include attachable trays that fold over wheelchair armrests. These designs
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suffer from similar problems to those for hygiene and hydration in that rigidity and poor
adjustability (e.g. typing angle) continue to persist. The PERCH-D device went through
five iterations with the current model consisting of a metal television mount with zip ties
wrapped around the footrest bracket of a motorized wheelchair.
One of the emphasis areas of our designs is on user experience (UX) during
completion of ADL including comfort and efficiency, allowing focus to be on an actual
task as opposed to stress induced by figuring out how the task can be performed in an
efficient and painless manner. For example, typing without an assistive tool often results
in anxiety which distracts from the primary purpose of the task which is the specific content
being written. This often results in significant changes to productivity as a result of nonergonomic one-handed typing and decline in continuous typing time (5-10 words per
minute) with completion of two or three sentences becoming strenuous. Prior to use of
PERCH-D, one need-knower was forced to position the laptop with the lid against a chair
or desk to improve typing efficiency to overcome the problem. Several new issues with
this arose including typing location restrictions and loss of laptop support which repeatedly
resulted in the device falling to the ground. One of the liberating features of the Mark IV
version of PERCH-D is typing and computer usage can be completed in any location such
as classrooms, offices, and conferences. A dramatic change in typing speed was reported
for one test user with the PERCH-D allowing 30 words per minute to be achieved.
6.3.4 Cupholder
Although drink holders are standard options on everything from cars, baby strollers,
and gym equipment, few wheelchair manufacturers sell drink holders for wheelchairs.
There are a number of shortcomings with current adaptive tools centered around eating and
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drinking needs of individuals with a lack of upper body strength. Drink holders, specifically
for wheelchairs, are underemphasized and do not offer efficient ways for positioning items
such as water bottles in a convenient and stable location. Some efforts have been made to
provide attachable cupholders for manual wheelchairs and select motorized wheelchair
brands, they are often positioned directly on the wheelchair frame or on the armrests,
protruding outward. This causes frequent issues including traversing through doorways in
which the cupholder may get caught on the frame or door itself potentially causing injury.
Positioning with respect to the mouth of the user is also a problem when attempting to lift
beverages upward for drinking and there are few drinking straw products long enough to
circumvent this problem.
The cupholder project is aimed at providing an adaptable solution for wheelchair
users for convenience and independence. Our design features two containers for carrying
both water for all day usage and a cupholder with a secondary straw to drink other hot or
cold beverages. The attachment will also include a thermo-responsive paint that will
provide a visual indication of whether the cup is hot or cold, and how full it is.
6.4 CONCLUSIONS AND FUTURE DIRECTIONS
These designs provide an initial starting point for eventual fabrication with the
long-term goal of providing modular devices to people with adaptive needs to assist in
ADL. We will move forward with national I-Corps team projects and look to incorporate
our findings in the next iterations of the projects. By interviewing additional experts and
potential users nationwide, we will broaden our designs to assist with a wider range of
needs caused by short- and long-term mobility limitations.
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CHAPTER 7: Conclusions.
In this work, docking, molecular dynamics, and electronic structure calculations
were used to: 1) gain an understanding of the molecular level interactions between
oligomeric polyelectrolytes and the MS2 protein capsid, 2) provide nanosecond scale
simulations to give direct molecular level insight into the mechanism of OPE- Aβ binding
and fluorescence, 3) study the driving forces and dynamics of curcumin binding to
amyloid-β protofibrils, and 4) simulate Aβ hairpins with zwitterionic and anionic lipid
membranes to better understand how Aβ disrupts lipid membranes. Furthermore,
computational and modeling tools were used to design adaptive design devices to help
improve activities of daily living for those living with short- and long-term disabilities.
Molecular level interactions between OPEs and the MS2 capsid were investigated
in Chapter 2. This work showed that these compounds display strong binding to the MS2
protein coat that is consistent with observed experimental results in which the viral capsid
structures are significantly disrupted upon exposure to OPEs in the dark. This provides
insight into the initial biocidal mechanism of OPEs against MS2. It is possible that OPEs
coat the capsid preventing attachment and infection of host cells. The approach taken in
this chapter is potentially also useful for a study of OPEs as viable agents against other
icosahedral based viruses that are worldwide threats to health such as human
papillomavirus (HPV), adenoviruses, and Zika virus.
Nanosecond simulations of OPE- Aβ binding as outlined in Chapter 3 found that
(i) Both anionic and cationic OPEs complex on Aβ 5-mers and 24-mers in a staggered
fashion with evidence of brick-type stacking (characteristic of J-dimerization) and (ii)
Binding sites of the OPEs are dependent on oppositely charged amino acids, with a clear
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preference for the anionic OPE12- to bind in sites enriched with positively charged residues
and vice versa for OPE24+. In addition, binding site analysis and ΔGBind decomposition
show non-polar residues are also important in the binding process based on hydrophobic
interactions. (iii) ΔGBind values from MM-GBSA calculations show that OPE complexation
is energetically favorable compared to binding as single molecules. Our calculated binding
energies of both OPEs are more favorable than other well-known dyes used to detect Aβ
aggregates including thioflavin T and Congo Red. (iv) OPE complexation on the Aβ 5mers and 24-mer results in restriction of rotation and increased planarity of their phenylene
ethynylene backbones. (v) Desolvation of the ethyl ester end termini of the OPEs occurs
readily upon binding as complexes.
In our study of the interactions between curcumin and Ab40 protofibril in Chapter
4, we showed that curcumin exhibits a pattern of non-specific, but distinct binding sites on
an Ab40 protofibril. Specifically, curcumin favorably binds either as complexes on the
protofibril surface or as single molecules at fibril ends. Curcumin self-assembly enhances
binding to Aβ protofibrils. In addition, the aqueous environment is a major factor driving
curcumin complexation on the protofibril surface. Binding of curcumin to numerous
hydrophobic locations could act to block toxic sites on the Ab protofibril surface.
Interactions of curcumin with the protofibril ends (in some cases resulting in deep insertion
of curcumin) may disrupt or interfere with further Aβ peptide assembly, causing “offpathway” worm-like fibril morphology observed in previous experimental work. The
molecular-level understanding of the driving forces and dynamics of curcumin binding to
Ab protofibril found in this study provide insight into how curcumin binds to protofibrils,
and how curcumin self-association can alter this binding affinity.
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Aβ aggregation on the microsecond timescale was investigated using model
membranes consisting of zwitterionic and anionic lipids in Chapter 5. It was found that the
results agree with previous experimental evidence that Aβ interacts with anionic lipids
including DMPG compared to membranes with zwitterionic DMPC. No insertion of the
peptides into the bilayer were observed, although an increase in interaction in the systems
containing higher concentrations of DMPG was found. There were few changes observed
in membrane thicknesses and area per lipid regardless of membrane composition.
Evaluation of peptide-peptide interactions showed prevalent self-assembly in the pure
DMPC system with all five monomers aggregating. As DMPG increased, the peptides
assembled in smaller aggregates with some remaining close to the membrane.
In Chapter 6, CAD was utilized to help test and create designs to improve ADL for
those living with disabilities. Four projects were discussed and evaluated to provide an
initial starting point for eventual fabrication with the long-term goal of providing people
with adaptive needs modular devices to assist in ADL. These projects were supported by
the NSF I-Corps Site Program at the University of New Mexico and will be further
investigated at the national I-Corps level. This will allow us to incorporate our findings of
user experience and customer discovery in the next iterations of the projects.
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